repNTI

8/17/2019 repNTI

1/162

1

MINISTRY OF HEALTH OF VIET NAM

HANOI MEDICAL UNIVERSITY

GENERAL STATISTICS OFFICE

CENTERS FOR DISEASE CONTROL AND

PREVENTION

WORLD HEALTH ORGANIZATION

G A T S (GATS)

V N 2010

HANOI 2010

8/17/2019 repNTI

2/162

2

C

GATS V N W G

D. Ha Va M Fa P Ha, Ha Ma UD. K Ba Ga, Fa P Ha, Ha Ma U

D. L T Ta Xa Fa P Ha, Ha Ma U

D. Pa T Ha V D, VINACOSH Sa O, M Ha

M. N Ta M Pa , VINACOSH Sa O, M Ha

MBA. N P D Sa a Ea Sa Da, Ga Sa

O

M. N T Qa D D Sa a Ea Sa Da, Ga

Sa O

M. Pa Va Ca D a Ta a S Maa D, Ga

Sa O

P C

D. Saa Aa La a a a US CDC

D. Ja Ha Fa V Na, a a a a a

, US CDC

M. Ga BN Saa aa a aa, US CDC

M. J M S aa, US CDC

D. Ga G E aa, U Ba, T Sa

U N Y

D. La A Saa aa, US CDCD. J Ba, E aa, Caa TaF KM. Da M

M. S La

IT , RTI Iaa

IT , RTI Iaa

M. Wa S Ga , US CDC

D. Ja Ma O WHO Ra V Na

D. Pa H Ka Naa Pa O, WHO V Na

D. Pa T Q Na Naa Pa O, WHO V Na

D. A Aa Ta O Sa, WHO Ra O W Pa

D. La Ia Ba E, WHO Haa, Ga

D. N T X V M , M Ha, V NaD. L N K D, Da Ma S Aa , M Ha,

V Na

P. Pa D T V Da Fa P Ha, Ha Ma U

8/17/2019 repNTI

3/162

3

C

F............................................................................................................................................ 7

A............................................................................................................................. 8

V N ........................................................................................................................... 9

E S........................................................................................................................... 10

1. I............................................................................................................................... 14

1.1 B T V N .................................................................................................. 14

1.2

C T C P V N ............................................................................. 15

1.3

S O....................................................................................................................... 16

2. M ............................................................................................................................. 17

2.1 S ........................................................................................................................ 17

2.2

S D......................................................................................................................... 17

2.3

Q ............................................................................................................................ 18

2.4 D C........................................................................................................................... 19

2.5 S A...................................................................................................................... 20

3. S P C ....................................................................................... 21

4.

T U............................................................................................................................... 24

4.1

T ........................................................................................................................ 24

4.2 S ............................................................................................................... 26

4.3 S .......................................................................... 28

4.4

C ................................................................. 31

4.5

F ................................................................................................... 36

4.6

N ........................................................................................ 39

4.7 A ............................................................................................................ 43

4.8

F ......................................................................... 43

4.9

T ..................................................................................................... 44

4.10 T .................................................................................................... 45

5. S S .................................................................................................................... 47

5.1

E S S W.................................................................................... 47

5.2

SHS ................................................................................................................ 50

5.3 SHS ..................................................................................................... 52

6.

C ................................................................................................................................... 56

6.1

I ........................................................................................................ 56

6.2

T ....................................................................................................... 58

6.3 S ................................................................ 59

6.4 C ..................................................................................................................... 62

7. E.................................................................................................................................. 64

7.1

L ....................................................................... 64

8/17/2019 repNTI

4/162

4

7.2 S ............................ 65

7.3

C ................................................................................................................ 67

7.4

C A................................................................................................................ 68

8. M ........................................................................................................................................ 69

8.1 A ....................................................................... 69

8.2

N ...... 73

8.3

N ............................................ 76

8.4 N ....................................... 78

8.5 N ............................................ 78

9.

K, A P ....................................................................................... 81

9.1

B ................................. 81

9.2 B (SHS) .......................... 85

9.3. B .................................................. 87

9.4. S ................................ 89

9.5. S ...................................................... 92

9.6. S ....................................................................... 96

10. D .................................................................................................................................. 98

10.1 M WHO FCTC: A 20 R, ............. 98

10.2

P WHO FCTC: A 8 P ............................ 99

10.3

O WHO FCTC: A 14 D

....................................................................................................................................... 100

10.4 W WHO FCTC: A 11 P ............................. 100

10.5

E WHO FCTC: A 13 T , ................. 101

10.6

R WHO FCTC: A 6 P ........ 101

11.

C R.......................................................................................... 103

11.1 C.............................................................................................................................. 103

11.2

R ................................................................................................................... 104

R...................................................................................................................................... 106

A A: Q ............................................................................................................. 108

A B: S D ............................................................................................................. 142

A C: E S E........................................................................................ 143

A D: T S S........................................................................................... 159

A E: G T ........................................................................................................ 161

8/17/2019 repNTI

5/162

5

Ta

Ta 31: N a a a a ()

GATS V Na, 2010. .......................................................................................................................................................21

Ta 32: D a ≥ 15 a a aa GATS V Na, 2010. ......................23

Ta 41: Pa a ≥15 a, a a a GATS V Na, 2010. .........................24

Ta 42: N a ≥15 a, a a a GATS V Na, 2010. ..............................26

Ta 43: Pa a ≥15 a, a a a a GATS V Na, 2010. ..27

Ta 44: N a ≥15 a, a a a a GATS V Na, 2010........28

Ta 45: Pa a ≥15 a a a a ,

a aa GATS V Na, 2010. ......................................................................................................30

Ta 46: N a ≥15 a a a a , a

a aa GATS V Na, 2010. .......................................................................................34

Ta 47: Pa a ≥15 a, , a a

aa GATS V Na, 2010. ............................................................................................................................37

Ta 48: Aa a a a a a a a ≥15

a, a a aa GATS V Na, 2010. .....................................................40

Ta 49: Aa a a a a a a a a 2034 a,

a GATS V Na, 2010. ................................................................................................................43

Ta 410: Pa a a, a , a ≥15 a a ,

a aa GATS V Na, 2010. ......................................................................................................44

Ta 411: Pa a ≥15 a, a a a a

aa GATS V Na, 2010. ............................................................................................................................45

Ta 412: Pa a ≥15 a, a a

a aa GATS V Na, 2010. ......................................................................................................46

Ta 51: Pa a a ≥15 a a a a a ,

a a a aa GATS V Na, 2010. .......................................................49

Ta 52: Pa a a ≥15 a a a a , a a a aa GATS V Na, 2010. .......................................................................................51

Ta 53: Pa a ≥15 a a a a a 30

a, a a a aa GATS V Na, 2010...........................................54

Ta 61: Pa ≥15 a a

a aa GATS V Na, 2010. ......................................................................................................58

Ta 62: Pa a ≥15 a, a

a aa GATS V Na, 2010. ......................................................................................................59

Ta 63: Pa ≥15 a a a a a aa a a

12 , a aa GATS V Na, 2010.................................................................61

Ta 64: Pa ≥15 a a a 12 , a

a a aa GATS V Na, 2010..........................................................63 Ta 71: Pa aa a ≥15 a, a a a a

a aa GATS V Na, 2010. ......................................................................................................64

Ta 72: Pa aa a ≥15 a, a a a

a a aa GATS V Na, 2010. ................................................................................66

Ta 73: Aa a a aa a ≥15 a,

a aa GATS V Na, 2010. ......................................................................................................67

Ta 81: Pa a ≥15 a aa a a 30 a a

a, a a a aa GATS V Na, 2010........................................71

8/17/2019 repNTI

6/162

6

Ta 82: Pa ≥15 a a a a aa a

a a a a 30 a, a aa GATS V

Na, 2010. ........................................................................................................................................................................75

Ta 83: Pa a ≥15 a a a a 30 a a a,

a aa GATS V Na, 2010........................................................................................77

Ta 84: Pa ≥15 a a a a 30 a a

a, a aa GATS V Na, 2010........................................................................79

Ta 85: Pa ≥15 a a a a 30 a a

a, a aa GATS V Na, 2010........................................................................80

Ta 91: Pa a ≥15 a a a , , a aa,

a, a aa GATS V Na, 2010. ......................................................................82

Ta 92: Pa ≥15 a a a , , a

aa, a, a aa GATS V Na, 2010. ..............................................83

Ta 93: Pa ≥15 a a a , , a aa,

a, a a a aa GATS V Na, 2010. ..............................84

Ta 94: Pa a ≥ 15 a a a ' a

, a a a aa GATS V Na, 2010. ............................86

Ta 95: Pa a ≥15 a a a a a, a, a

a aa GATS V Na, 2010. ......................................................................................................88

Ta 96: Pa a ≥15 a a a a a a

a a a, a a a aa GATS V Na,

2010. .................................................................................................................................................................................89

Ta 97: Pa a ≥15 a a a a a a a a,

a a a aa GATS V Na, 2010. ...................................................93

Ta 98: Pa a ≥15 a a a a , a a

a aa GATS V Na, 2010. .......................................................................................97

8/17/2019 repNTI

7/162

7

F

T a a a a a a .

A W Ha Oaa, 10 Va a a

a a 2020 a a a a. T Naa Ha S 2001

2002 a a a a a aa 56.1% a a a (31% a a

a 1524, a a 60% a a a 2535). T Va a

' a , M Ha a a FCTC

a.

T Ga A Ta S (GATS) Va 2010 Va a a

a a. T a M Ha, a a a

, aa a a a R N. 12/2000/NQCP

Naa Ta C P a a .

W aa a aa a aa

aa, a B Pa, C Da C a P Aaa,

CDC Fa, W Ha Oaa, Ga Sa O Va, a Ha Ma

U. T aa a a aa aa a a

a a Va.

N T X, MD, PD

V M H

8/17/2019 repNTI

8/162

8

A

W a a a a aa a aa aa, Ga

A Ta S (GATS), a aa aa a a a a

a a, a V Na. F a, aa B Pa a a aa a GATS

a , V Na.

S a , a a aa a aa

CDC a, a , aa aa, a a , a

a aa GATS a a aa a . O aa

CDC aa .

W a a a aa , a a M

Ha a M Pa a I . E a Va S C S a Ha, Ga Sa O a Ha N Ma U

a .

Caa a a a a a aa a a

a a aa.

O a W Ha Oaa, Haa Ra O C

, aa GATS a, a a aa aa, a a

aa a aa a.

T a a a , a a

. W , a .

8/17/2019 repNTI

9/162

9

V N

A 331,210

T 85.8

P 1.137%

T 1.93 /

R 70%

L 72.8

M 1 16 1,000

M 5 25 1,000

M 75 100,000

M 5 18.9%

GDP US$ 91,854

P 12.3%

L 90.3%

* : 2009

8/17/2019 repNTI

10/162

10

E S

Ta a a a a,

. P a a 5 a a a a a 8 a a

2030. V Na a a . T a a

a 15 a a 2002 a 56.1% a a 1.8% a . Ta a a a

a V Na. A a V Na a a a 40,000 a a

2008 a a 50,000 a aa 2023. E a a V

Na aa a a, a a . A a

a a a a a a a

a a.

T Ga A Ta S (GATS) a a a a Fa 2007 a a

aa a a a a. T GATS a a 14

a a a a a a : Baa,

Ba, Ca, E, Ia, M, P, Pa, Ra Fa, Taa, T, Ua, Ua a V

Na.

T GATS a:

T a a a a a a a a.

T aa a a ( a ) a a a a aaa a a V Na.

T a aa a a a aa.

T a a FCTC MPOWER aa.

GATS V Na 2010 a a aa a a a a a 15 a a . A a a a a . Saa a aa

(a/a). T Pa I a a 15% a a a aa (EA) a Ga Sa

O, V Na, 2009 C. T Pa II a a a a a EA 15% a a.

A a 9,925 a , 64.3 a a 15 a a V

Na. T a a a 92.7%.

T GATS V Na a , a aa, a (

a ), a, a , , a, a , a, a . T Ga

Sa O a a aa a W Ha Oaa V Na,

Va M Ha, a Ha Ma U aa . Daa

22 Ma 2010 13 Ma 2010 a 63 V Na. A Va a

a a aa.

8/17/2019 repNTI

11/162

11

T U

I V Na, 47.4% , 1.4% , a 23.8% a (15.3 a) a. O

, 81.8% a a a. 83.7% a, a 26.9% a . O 1.3%

a (0.3% a a 2.3% a) a.

A 69.0% a a 10 a a; 29.3% 20 a a. T aa a a a a a 19.8 a , 23.6 a , a 19.9 a a.

A a , 66.2% a a a 30 a a .

S S (SHS)

A 55.9% a ( a 8 ) a a SHS a

a a 30 a (68.7% a a a 41.4% a a). A ,

a SHS a a a 49.0% a ( a 5 ),

62.8% a a a 41.3% a a.

A 73.1% a a 15 a a a ( a 47 ) a

SHS a (77.2% a a a 69.2% a a). A , a SHS a

a 67.6% (a a 33 ), 68.8% a a a 65.2% a a.

A a a a a a 30 a, a

a/a/a (92.6%), aa (84.9%). T a a

a a 23.6% a 22.3%, . T a a a

54.3% a 38.7%, .

C

A 29.3% a , 67.5% a a

a . A 9.5% ( 1.5 )

a a 55.3% a a a a a a 12 .

A a a aa (HCP) 12 , 34.9% a aa a . L a (29.7%) a a HCP .

I a 12 , 24.4% a a a, a a 0.4% a

a (B Va) a . O 3.0%

a .

E

T a a a a 20 aa a a VND 5,500 (a US$ .29). T a a

a a a VND 1,096,000 (a US$ 57). T a 100 a

aa a a a a G D P (GDP) aa a 2.7%.

A 71.3% a a a a .

M

T a a a a a,

a a a 30 a a 16.9%.

I a 30 a, 91.6% a a a aa a, aa

a a a a a a. T a a a (85.9%),

a (42.8%) a a a a (38.2%). T a aa

a a a a 7.7%.

8/17/2019 repNTI

12/162

12

I a 30 a, 92.4% a a a a a.

K, A P

A a a (95.7%) a a a a a . T a

a aa a a a a a: a (95.6%), (70.3%), a

a aa (62.7%). A 55.5% a a a a a

a.

A 87% a (82.2% a 88.5% ) a a SHS a

.

GATS V Na 2010 aa a a a a aa

a . I a, a a a a, a

a , a aa a, a a, a

a a. T a a a a

a , a, a a a .

T GATS V Na 2010 a a a a V Na aa

a a, a :

T a a a 2002 (a: 56.1% 47.4%; a: 1.8% 1.4%), a a .

M Va aa a a SHS, SHS a a ,, a a, a. T a a a,, a a .

S a a a a a V Na. I a, aa a a aa .

GATS V Na a a V Na . Ma a a a .

E a a a V Na (a 30% a a aa) a a a.

O a a a a a a a a aaa ( a, a aa a ).

A a a a a a a a a , a aa a a a a (.., a, a a a a) a .

E a a V Na aa a a, a

a . Ia P M D N. 1315/QĐTT Raa A

Pa Ia WHO Fa C Ta C . T A

Pa a WHO MPOWER , a a aa aa

a a :

M : S a a a,

() a a ; () a ; a () a a,

a . I GATS, a a GATS

.

8/17/2019 repNTI

13/162

13

P :

I a a .

Aa a.

O : S a a a a aa

; a a a a a a aa a.

W :

Aa a a a a a .

Ea a aa aa a a a a a.

E , , : S a a a a

a a a, a .

R : Ia a a a a a

a a a , a a a . Aa a a a

a .

8/17/2019 repNTI

14/162

14

1. I

Ta a a a a,

[1, 2]. P a a 5 a a a a a 8 a

a 2030[1]. U a a, a a a a

. A a a a a a

a a a.

T W Ha Oaa (WHO) Ta F Ia (TFI) a a a a a

a a, a a aa a, a, a

a a a a . T a

a a a WHO Fa C Ta C (FCTC) [3] a

MPOWER aa [4]1 a a a FCTC. T FCTC a a

a TFI Pa a a

MPOWER.

I A 2006, WHO a U Sa C Da C a P (CDC) a

a a a a a a a a aa

. T a a a a a

a a a a a a aa aa .

T B Ia R Ta U aa a a a a

a a a a Ga Ta Sa S (GTSS), a

a a a a: Ga Y Ta S (GYTS),

Ga S P S (GSPS), a Ga Ha P S S (GHPSS).

T Ga A Ta S (GATS) a a a a Fa 2007 a a

GTSS. T GATS a aa a a a

a. R GATS a a, a a a a

, a a a

GATS.

T GATS a a 14 a a a a a

a : Baa, Ba, Ca, E, Ia, M, P, Pa, Ra Fa,

Taa, T, Ua, Ua a V Na.

T CDC, CDC Fa, J H B S P Ha (JHSPH), RTI Iaa, WHO a

a a GATS.

1.1 B T V N

V Na a a . T a a a

15 a 2002 a 56.1% a a 1.8% a [5]. A a 200102, 69.1%

a , 23.2% a a , a 7.7% [5]. Va a

a , a a a a.

H, a a aa, a a a . Ba

1 T MPOWER aa a a a a a a : M a

a ; P a ; O a ; Wa a a a;

E a a a, , a ; a Ra a a.

8/17/2019 repNTI

15/162

15

, a a a a a aa a

aa [6]. I 2007, a a a a 1315 a a 3.3% a. T a

a a (5.9%) a a a a a (1.2%)[7].

I V Na, a a a a a

a a a . I 2001/2002, 63% a

a 71% 6 a [5].

Ca a a a. T a V Na a a aa

a 5800 a a, a a a 70%80% aa. T a a

a 2000, a a , a a

a a a , a a . O a a

a 40004500 a a. I 200006, a a a a 42%

[8].

Ta a a a a V Na. A a V Na a a a

40,000 a a 2008 a a 50,000 a aa 2023 [9]. I a

, Na a. a a 66,00076,000 a 2005, a 9.7% 11.1%

a a a 6.8%7.7% DALY V Na 2006. Caaa a a a

a a a a a a a [10].Ta a a a, a a a aa

aa . T a ( a, a a a, a

a a [COPD]) aa a V Na a a VND 1100

(a US$ 75 ) 2005 [11]. T, a a a a aa aa . I 1998,

Va aa a 6000 VND a, a 1.6

a 10.6 a. I a a , 11.2%

a [6]. I 2007, a a VND 14.000 ,

a 510% a [12].

1.2 C T C P V N

Ta a V Na a a 20 a a Va a

a a a :

I 1986, G V Na a ( a D M), a a a 15 a .

I 1989, T 'La P P' Ha' a a, A 5 3, a a, a a a. T a a a a 1991. I Ma1989, M Ha a V Na C S a Ha (VINACOSH), a a .

I 1990, C M a a. I a a a V Naa W Ta Oaa (WTO) Jaa 2007.

A 1992 aa , a a a a .

T a a a a a 1994, a a a a 1995 (a 32% 50% a ), a a a aa a.

S a a a 1996, a a a a aa a 1997

I 2000, G a a a a a.

8/17/2019 repNTI

16/162

16

G aa a a a P Ma R a G RN 12/2000/NQCP "Naa Ta C P 2000 2010 [NTCP], a a M Ha a a ( Ta a Fa) a aa. T a NTCP a a 50% 20% aaa a a 2%. T NTCP a, , a a, a aa. I a a a a a a, a a [13].

V Na Fa C Ta C (FCTC) 8 A 2003 a a 17D 2004.

I 2006, V Na Sa C Ta (SCT) a a a a a a a a a a 55% a . T SCT a 65% a Jaa 2008.

I 2007, G D N. 12/2007/CTTT a a VNa, a a: 1) a a a a ; 2) a a a a a a; 3) aa a a a ( 30% a a aa); 4) a a; 5)a a a, a a; a 6) a a a. T a M Ha, aa a aa V Na [14].

O 21 A 2009, P M D N. 1315/QĐTT Raa A Pa Ia WHO Fa C Ta C. T A Pa , a a a a a a a a FCTC [15].

E a a V Na aa a a, a a

. F a, a a a a a, a

aa FCTC aa a a. T M Ha a a a

a a a. A, a a a a a Naa A.

1.3 S O

T GATS a:

T a a a a a a a a

T aa a a ( a ) a a a a aaa a a V Na

T a aa a a a aa

T a a FCTC MPOWER aa

8/17/2019 repNTI

17/162

17

2. M

2.1 S

T GATS V Na a a aa a a a a

a 15 a V Na a a . T a a

a V Na Va .

T a a 15 a a :

W (.. ),

Ia a a a a a a a (.. a ),

W a a, , a .

S a a a a a a a a

a , a a , a a a aa , a a

a a a a a a. T a a a

a a . C,

I a a a a a a a a aa a a , a .

I a a a a a a a , a .

2.2 S D

T GATS V Na a a A B. A a a aa a

a a a a .

A GATS a , 8,000 a a a a aa a a/a aa. Ba a aa , a a a a

a a 35%. A a a a, a a a

a 11,142. T a a aa (EA) a a a a a a. Ba

a a a aa, GATS a 18 a a EA a 16

a a EA. T a a 657 EA a a 11,142 . T a EA a

a aa a 6 aa, a a .

I 2009, Ga Sa O (GSO), V Na a a a . Ma, GSO

a a 15% a a a a aa a a. T 15% a a a a

EA a 15% a V Na a 3 . T 132

, , . T 294 a a aa . T

256 a a a . T GATS a a a 15% a a a

aa 3 a a a aa (6 aa a).

A a a, a a (PSU) a a a aa (EA). T a a a a

EA, 15% a a, a a a a, a

GSO V Na 2009 . F a 6 aa, a EA a . A

a a (PPS) a a , a a

a EA PPS a a a a a EA a a.

8/17/2019 repNTI

18/162

18

A a a, 18 a EA a 16 a EA

a a a. O a a

a a .

N a a EA a aa. T

a a a a aa a a a a a. T

a a a a a a a. T a

a A B.

2.3 Q

T GATS V Na a . A a a (

a A A):

B : G, a, a, a, a .

T : Pa (a , a a , a a), /aa , a a a , a , (a,a , a a), , a a.

S : Pa (a , a a , a a), /a

a, a a a a, a (, a, , .), , a a.

C: A a aa , . Saa a a a.

S : S a , a a , a a, a a 30 a a, /, aaa, aa, aa. T a aa a a , , a a, a, , ., a a a a .

E: T a a a , a (), a a a, a a .

M: E a a , a, a, , a/aa,a, I, aa, a, a ; a; , a, a a a; a a; a a a a a a; a aa aa a. Sa a a. T 30 a.

K, : K a a a a.

T GATS a a aa Va :

Taa a GATS a Va a aa .

R a aaa Va a . S

a a. Ba aa aa Va a E a aa .

T aaa aa a a a CDC aWHO/WPRO a .

T aaa aa a a Qa R C .

A a a a a 120 a (60 a a 60 aaa). I , a aa a , ,

8/17/2019 repNTI

19/162

19

a, a , /a aa,aa a , a, .

T GATS a a a a a a WHO a CDC.

T a a a a Qa R C .

2.4 D C

Daa a Ga Sa O, W Ha Oaa V

Na, Va a Ha Ma U.

/

T 26 aa a GATS V Na 2010. Ea a a a a 4

a a aa. T a a a

aa a GSO aa. T a a

GSO a , a GSO aa . I a aa

, a a GATS a a (PAQ) a a

a a.

T Sa a Ea Sa Da, Pa Sa O a

Ha Ma U. S a . I a,

a a (PAQ) (.., a aa

a aa a).

T 6a a a 2 : N (Ha) Ma 27, 2010 a

S (Na Ta C) Ma 510, 2010. T a a , ,

a, a a aa aa a . L

/ GSO, WHO, CDC, Va a HMU.

(.., )

Ha a aa. Ea a a a a PAQ. A a a

a a a a a a a PAQ

. A PAQ, a a .

O aa, a a 90 . A a a a

a / IPAQ . I a aa. A

a a, a aa a a

Ta a a a aa a, aa ,

a a , a a a . I a, a a a

aa a a a a (a 10% )

aa a . I a EA a aa, a a a .

Daa a 22 Ma 2010 13 Ma 2010 a 63 V Na.

T GSO a 10 a, GSO a HMU, a a a

; a a a, a , aa ,

8/17/2019 repNTI

20/162

20

., a a; ; 10% ;

aa a a a a ; a a aa GSO a

I . IT IPAQ a a a a

IPAQ.

A Va.

/

R a a a a a a aa a

a , a a aa, a a a a, aa

. Paa a aa a 1517. Va a

a a.

S aa GSO a a a I. IT a aa

a a a. A aa a , IT aa,

, a aa SPSS a STATA a.

2.5 S A

SPSS 17.0 a a a. Vaa a aa a a a

a. T Ta aa a SPSS a aa. Sa a 95%

a a a. T a, a a a , a

A C a a.

8/17/2019 repNTI

21/162

21

3. S P C

T a a a a a a

E! R . . O 11,142 a , 10,383 , a

a 96.9%. T a a a a aa a a aa

(97.5% a 96.5%, ). Oa, 0.6% . A

10,383 a , 9925 a

a 95.7%. T a a a a a aa a a a

aa (96.3% a 95.0%, ). Oa, 0.6% a . I

GATS V Na 2010, a a a 92.7% (93.9% a aa a 91.7% a ).

T 32 a a a a a aa. T

9,925 a a 64.3 a a 15 a V Na. O

a, 48.6% a 51.4% . B a , a 2544 a a

(41.9%) a 65 a a a a a (8.8%). T a 15 a V Na

a aa. T a a a a a (52.5%)

a a (26.0%). P a a a 7.2% a. T

a a a a Fa (49.6%), S/Sa (19.2%) a P/D(12.9%). O a Maa/Pa (6.6%); C/ (5.2%); O (2.0%);

F/F (1.8%) a O (2.7%).

T 31: N ()

GATS V N, 2010.

R

U RT

N P N P N P

C (HC) 5525 92.2 5158 94.4 10383 93.2

C N (HCNE) 1 0.0 0 0.0 1 0.0I (HINC) 5 0.1 9 0.0 14 0.1

N (HNS) 2 0.0 5 0.0 7 0.1

R (HR) 55 1.0 9 0.2 64 0.6

U (HUO) 216 3.8 166 6.5 382 3.4

A a (HAND) 29 0.5 18 0.2 47 0.4

O1 (HO) 137 2.4 107 0.9 244 2.1

Ta H S 5670 100 5472 100 11142 100

() (%)2 96.5% 97.5% 96.9%

C (PC) 4958 94.9 4967 96.3 9925 95.6I (PINC) 2 0.0 4 0.1 6 0.1

N (PNE) 7 0.1 2 0.0 9 0.1

R (PR) 56 1.1 9 0.2 65 0.6

Iaaa (PI) 50 1.0 44 0.9 94 0.9

O1 (PO) 152 2.9 132 2.6 284 2.7

Ta N Sa P 5225 100 5158 100 10383 100

() (%)3 95.0% 96.3% 95.7%

() (%)4 91.7% 93.9% 92.7%

8/17/2019 repNTI

22/162

22

1 O N H a a .

2 Caa H R Ra (HRR) :

(HC + HCNE) *100

HC + HCNE + HINC + HNS + HR + HO

3 Caa P R Ra (PRR) :

PC *100PC + PINC + PR + PI + PO

4 Caa Ta R Ra (TRR) : (HRR PRR) / 100

N:A (.., ) a a GATS. T, a (HINC) a a.A [PC] a a a E1 a a a B1/B2/B3. R a a (PINC) GATS a , a a.

8/17/2019 repNTI

23/162

23

T 32: D ≥ 15 GATS V N, 2010.

WD

C P

(95% CI1)

N A

( )

U N

A

O 100 64,321 9,925

Ma 48.6 (47.3, 49.9) 31,259 4,356

Fa 51.4 (50.1, 52.7) 33,063 5,569

A ()

1524 25.9 (24.6, 27.2) 16,637 1,656

2544 41.9 (40.6, 43.2) 26,944 4,251

4564 23.4 (22.4, 24.5) 15,065 2,886

65+ 8.8 (8.2, 9.5) 5,675 1,132

Ua 30.7 (30.0, 31.4) 19,725 4,958

Ra 69.3 (68.6, 70.0) 44,596 4,967

2

Pa 26.0 (24.2, 27.8) 12,377 2,034

L a 52.5 (50.8, 54.3) 25,031 3,981

U a 14.3 (13.1, 15.5) 6,794 1,023

C a 7.2 (6.6, 7.9) 3,447 1,227

Maa/Pa 6.6 (5.9, 7.5) 3,120 845

O W 2.0 (1.6, 2.3) 916 220

S/Sa 19.2 (17.8, 20.6) 8,991 1,589

Fa 49.6 (47.3, 51.8) 23,255 3,069F/F 1.8 (1.3, 2.6) 867 120

C/M 5.2 (4.5, 6.0) 2,442 317

P/D 12.9 (11.7, 14.3) 6,063 834

O 2.7 (2.3, 3.3) 1,272 2481 95 % C Ia2 Ea a 25+ a

8/17/2019 repNTI

24/162

24

4. T U

4.1 T

Ta a a a a a a a .

C a a a aa . N a

a a .

T 41 a a 15 a a , a a a . T a

a a a 23.8%. Ta a a aa a a a

(47.4% . 1.4%, ). Oa, 19.5% a > 15 a a (38.7% a a a 1.2% a

a) a 4.3% aa (8.7% a a a 0.2% a a). A , 81.8%

a a 18.2% aa .

N a 76.2% a. Oa, 6.8% a a a

69.8% a . T a 64.4% a a a 3.4%

aa .

T 41: P ≥15 , GATS V N, 2010.

S S O M F

(95% )

C 23.8 (22.7, 24.9) 47.4 (45.4, 49.4) 1.4 (1.0, 2.1)

Da 19.5 (18.4, 20.5) 38.7 (36.9, 40.6) 1.2 (0.8, 1.8)

Oaa 4.3 (3.8, 4.9) 8.7 (7.6, 9.8) 0.2 (0.1, 0.4)

Oaa , a 1.5 (1.2, 1.8) 3.0 (2.5, 3.6) 0.1 (0.0, 0.3)

Oaa , a 2.8 (2.4, 3.3) 5.7 (4.8, 6.7) 0.1 (0.0, 0.3)

N 76.2 (75.1, 77.3) 52.6 (50.6, 54.6) 98.6 (97.9, 99.0)

F a 6.4 (5.8, 7.1) 12.7 (11.5, 14.0) 0.5 (0.3, 0.8)

N a 69.8 (68.6, 71.0) 39.9 (37.9, 41.9) 98.0 (97.3, 98.5)

F aa 3.4 (3.0, 3.9) 6.5 (5.6, 7.5) 0.5 (0.3, 0.8)

N 66.4 (65.1, 67.6) 33.5 (31.5, 35.5) 97.5 (96.8, 98.1)

N: C a a aa ( a a) .

T a a V Na a a 15.3 (14.8

a a 477,000 a). T a a a a 12.5 (12.1 a

a 403,000 a). T a aa a a 2.8 ( a 2.7 a

a 76,000 a) (

8/17/2019 repNTI

25/162

25

T 42).

8/17/2019 repNTI

26/162

26

T 42: N ≥15 , GATS V N, 2010.

S S O M F

C 15,294 14,817 477

Da 12,511 12,110 401

Oaa 2,783 2,708 76Oaa , a 970 935 35

Oaa , a 1,813 1,772 41

N 49,027 16,441 32,586

F a 4,141 3,966 175

N a 44,886 12,475 32,411

F aa 2,184 2,019 165

N 42,702 10,456 32,246


4.2 S

S a V Na a . A )

T 43, a a a a 1.3% (0.3% a a 2.3% a). A

a, 1.0% a a (0.1% a a a 1.8% a a) a 0.3% aa

a (0.2% a a a 0.5% a a). A a , 74.4%

a a 25.6% aa .

Oa, 98.7% a a . O 0.2% a a 0.3%

aa .

T a a V Na a a 884,000. O , a 92,000

a a a 752,000 a (

8/17/2019 repNTI

27/162

27

T 44)

T 43: P ≥15 , GATS V N, 2010.

S T U S O M F

(95% )

C 1.3 (1.0, 1.7) 0.3 (0.2, 0.5) 2.3 (1.8, 3.0)Da 1.0 (0.8, 1.3) 0.1 (0.0, 0.2) 1.8 (1.4, 2.4)

Oaa 0.3 (0.2, 0.5) 0.2 (0.1, 0.4) 0.5 (0.3, 0.9)

Oaa , a 0.1 (0.1, 0.3) 0.0 (0.0, 0.1) 0.2 (0.1, 0.5)

Oaa , a 0.2 (0.1, 0.4) 0.2 (0.1, 0.4) 0.3 (0.1, 0.6)

N 98.7 (98.3, 99.0) 99.7 (99.5, 99.8) 97.7 (97.0, 98.2)

F a 0.2 (0.1, 0.3) 0.0 (0.0, 0.1) 0.4 (0.2, 0.6)

N a 98.5 (98.1, 98.8) 99.7 (99.5, 99.8) 97.3 (96.6, 97.9)

F aa 0.3 (0.2, 0.4) 0.2 (0.1, 0.5) 0.3 (0.2, 0.6)

N 98.2 (97.8, 98.5) 99.4 (99.2, 99.6) 97.0 (96.3, 97.6)


8/17/2019 repNTI

28/162

28

T 44: N ≥15 , GATS V N, 2010.

S T U S O M F

C 844 92 752

Da 628 33 595

Oaa 216 59 157

Oaa , a 79 7 71

Oaa , a 137 52 85

N 62,749 30,799 31,950

F a 122 4 118

N a 62,627 30,795 31,832

F aa 178 75 103

N 62,450 30,720 31,729


4.3 S

8/17/2019 repNTI

29/162

29

T 45 a a , a a

aa. T a a ( a ) a a a

a a a (47.4% . 1.4%, ).

T a a a a a a 4564 (29.7%) a 2544 (28.8%) a a

a a 1524 (13.3%) a 65 a a (15.0%). T a a a

a a a a a a. A a, a a a

a a 4564 (59.5%) a 2544 (56.7%) a a a 1524 (26.1%). A a, a a a 45 a a (2.9%) a a a 1524

(0.3%).

F a a a, a a a a a a aa (a:

23.3% .24.0%, ; a: 47.7% . 47.3%, ; a: 1.0% . 1.7%, ).

B a, a a a a a a a

a a . I a a a, a a

a a a (a: 61.4%; a: 4.4%) a a

(a: 39.7%; a: 0.3%). F a a a, a a

a 0.3%.

B a, a a a a a C/M (65%), F/F (56.0%). T a a a a O

W (13.9%). I a a a, a a a a F/F

(a: 74.5%; a: 7.8%) a a O W (a: 34.0%; a: 0%).

8/17/2019 repNTI

30/162

30

T 45: P ≥15 ,

GATS V N, 2010.

T CD

C

A

A 1 M H W P

O

2

(95% )

O 23.8 (22.7, 24.9) 19.9 (18.7, 21.1) 19.5 (18.4, 20.7) 1.1 (0.8, 1.6) 6.4 (5.6, 7.3) 0.1 (0.1, 0.3

A ()

1524 13.3 (11.3, 15.6) 11.9 (10.1, 14.1) 11.9 (10.1, 14.1) 0.3 (0.1, 1.0) 3.0 (2.0, 4.4) 0.0

2544 28.8 (27.1, 30.6) 25.1 (23.4, 26.9) 24.9 (23.2, 26.6) 1.1 (0.7, 1.7) 7.2 (6.0, 8.6) 0.2 (0.1, 0.4

4564 29.7 (27.5, 31.9) 22.7 (20.7, 24.9) 22.0 (20.0, 24.1) 1.8 (1.2, 2.6) 9.4 (7.9, 11.2) 0.2 (0.1, 0.6

65+ 15.0 (12.8, 17.6) 11.0 (9.0, 13.4) 9.6 (7.8, 11.9) 1.9 (1.1, 3.2) 4.7 (3.5, 6.4) 0.2 (0.0, 0.6

Ua 23.3 (21.9, 24.7) 22.0 (20.7, 23.5) 21.9 (20.5, 23.3) 0.4 (0.2, 0.7) 2.5 (2.0, 3.2) 0.1 (0.0, 0.2

Ra 24.0 (22.5, 25.6) 18.9 (17.4, 20.6) 18.5 (17.0, 20.0) 1.4 (1.0, 2.1) 8.1 (7.0, 9.5) 0.2 (0.1, 0.4

3

Pa 24.3 (21.8, 26.9) 20.1 (17.7, 22.7) 18.7 (16.4, 21.1) 3.3 (2.2, 5.1) 5.0 (3.8, 6.7) 0.4 (0.1, 1.3

L a 29.8 (28.1, 31.6) 24.0 (22.2, 25.8) 23.7 (21.9, 25.5) 1.0 (0.7, 1.5) 9.8 (8.4, 11.4) 0.1 (0.0, 0.3

U a 27.4 (24.1, 30.9) 24.1 (21.0, 27.4) 24.1 (21.0, 27.4) 0.0 6.7 (4.9, 9.0) 0.3 (0.1, 0.9

C a 21.5 (18.8, 24.5) 20.0 (17.3, 23.0) 20.0 (17.3, 23.0) 0.0 (0.0, 0.3) 2.7 (1.8, 4.0) 0.1 (0.0, 0.5

Maa/Pa 28.2 (23.9, 33.1) 27.0 (22.7, 31.8) 27.0 (22.7, 31.8) 0.1 (0.0, 0.4) 3.3 (1.8, 5.9) 0.1 (0.0, 0.4

O W 13.9 (9.4, 20.1) 13.8 (9.3, 20.0) 13.8 (9.3, 20.0) 0.0 0.0 0.0

S/Sa 20.3 (17.9, 22.9) 18.5 (16.2, 21.1) 18.5 (16.1, 21.0) 0.3 (0.1, 0.7) 3.7 (2.6, 5.2) 0.1 (0.0, 0.5

Fa 28.6 (26.6, 30.7) 22.4 (20.3, 24.6) 21.7 (19.7, 23.8) 2.1 (1.3, 3.3) 9.4 (8.0, 11.0) 0.3 (0.1, 0.8

F/F 56.0 (44.7, 66.8) 50.1 (38.5, 61.6) 47.8 (36.3, 59.5) 4.9 (1.4, 15.8) 6.0 (2.1, 15.7) 0.0

C/M 65.0 (58.6, 71.0) 56.8 (49.7, 63.6) 56.8 (49.7, 63.6) 1.8 (0.6, 5.0) 21.1 (15.6, 27.7) 0.1 (0.0, 1.0

P/D 32.0 (28.2, 36.1) 28.2 (24.6, 32.1) 28.1 (24.5, 32.0) 0.4 (0.2, 1.2) 6.6 (4.7, 9.2) 0.1 (0.0, 1.0

O 35.0 (27.9, 42.8) 30.4 (23.1, 38.7) 29.6 (22.5, 37.9) 0.9 (0.1, 4.9) 9.6 (5.5, 16.1) 0.0

M 47.4 (45.4, 49.4) 39.7 (37.5, 41.9) 39.1 (37.0, 41.2) 1.9 (1.3, 2.6) 13.0 (11.4, 14.9) 0.2 (0.1, 0.4

A ()

1524 26.1 (22.4, 30.2) 23.4 (19.8, 27.3) 23.4 (19.8, 27.3) 0.5 (0.2, 1.1) 5.9 (3.9, 8.6) 0.0

2544 56.7 (53.8, 59.5) 49.5 (46.6, 52.5) 49.2 (46.3, 52.1) 2.0 (1.3, 3.0) 14.2 (12.0, 16.9) 0.2 (0.1, 0.5

4564 59.5 (56.0, 62.8) 45.4 (41.8, 49.1) 44.1 (40.5, 47.8) 3.1 (2.1, 4.7) 19.6 (16.6, 23.0) 0.4 (0.1, 1.0

65+ 33.3 (28.5, 38.4) 23.7 (19.3, 28.7) 21.7 (17.6, 26.6) 2.8 (1.4, 5.4) 11.7 (8.7, 15.5) 0.0

Ua 47.7 (45.3, 50.2) 45.2 (42.8, 47.7) 45.0 (42.5, 47.5) 0.7 (0.3, 1.3) 5.3 (4.2, 6.6) 0.2 (0.1, 0.5

Ra 47.3 (44.6, 49.9) 37.3 (34.5, 40.2) 36.6 (33.8, 39.4) 2.4 (1.7, 3.5) 16.4 (14.1, 19.0) 0.2 (0.1, 0.5

3

Pa 61.4 (56.7, 65.8) 50.9 (45.8, 55.9) 48.1 (43.3, 52.9) 7.1 (4.7, 10.6) 13.8 (10.4, 18.1) 0.2 (0.1, 1.0

L a 57.3 (54.5, 60.1) 46.1 (43.0, 49.1) 45.6 (42.6, 48.6) 1.9 (1.2, 2.8) 18.9 (16.2, 21.9) 0.2 (0.1, 0.5

U a 48.9 (43.8, 54.0) 42.9 (38.0, 48.0) 42.9 (38.0, 48.0) 0.0 12.0 (8.9, 15.9) 0.5 (0.1, 1.6

C a 39.7 (35.2, 44.4) 36.9 (32.5, 41.6) 36.9 (32.5, 41.6) 0.1 (0.0, 0.6) 5.1 (3.4, 7.3) 0.2 (0.1, 1.0

Maa/Pa 46.1 (39.6, 52.7) 44.0 (37.6, 50.7) 44.0 (37.6, 50.7) 0.1 (0.0, 0.6) 5.5 (3.0, 9.7) 0.1 (0.0, 0.6

8/17/2019 repNTI

31/162

31

T CD

C

A

A 1 M H W P

O

2

(95% )

O W 34.0 (23.8, 46.0) 33.7 (23.5, 45.7) 33.7 (23.5, 45.7) 0.0 0.0 0.0

S/Sa 50.0 (45.0, 55.0) 45.6 (40.6, 50.7) 45.5 (40.5, 50.6) 0.5 (0.2, 1.6) 9.2 (6.5, 12.9) 0.3 (0.1, 1.2

Fa 55.3 (52.0, 58.5) 43.2 (39.7, 46.8) 42.1 (38.7, 45.6) 3.6 (2.4, 5.4) 18.6 (15.7, 21.8) 0.3 (0.1, 0.8

F/F 74.5 (60.4, 84.8) 66.2 (52.1, 78.0) 63.1 (48.9, 75.3) 5.2 (1.2, 19.2) 8.3 (2.9, 21.4) 0.0

C/M 69.7 (63.0, 75.6) 60.8 (53.3, 67.8) 60.8 (53.3, 67.8) 1.9 (0.7, 5.4) 22.6 (16.7, 29.8) 0.2 (0.0, 1.1

P/D 55.3 (49.4, 61.1) 48.9 (43.1, 54.8) 48.8 (43.0, 54.7) 0.8 (0.3, 2.1) 11.3 (8.1, 15.5) 0.2 (0.0, 1.7

O 63.0 (52.9, 72.0) 54.4 (41.8, 66.5) 53.0 (40.6, 65.1) 1.6 (0.3, 8.7) 17.5 (10.4, 28.1) 0.0

F 1.4 (1.0, 2.1) 1.2 (0.8, 1.8) 1.0 (0.6, 1.5) 0.4 (0.2, 0.9) 0.1 (0.1, 0.3) 0.1 (0.0, 0.4

A ()

1524 0.3 (0.0, 1.4) 0.3 (0.0, 1.4) 0.3 (0.0, 1.4) 0.2 (0.0, 1.6) 0.0 0.0

2544 0.9 (0.5, 1.7) 0.7 (0.3, 1.4) 0.6 (0.3, 1.3) 0.2 (0.0, 0.8) 0.2 (0.1, 0.4) 0.1 (0.0, 0.5

4564 2.9 (2.0, 4.1) 2.4 (1.6, 3.5) 2.1 (1.4, 3.1) 0.5 (0.3, 1.1) 0.3 (0.1, 0.8) 0.1 (0.0, 0.5

65+ 2.9 (1.6, 5.4) 2.6 (1.4, 4.8) 1.6 (0.7, 3.6) 1.4 (0.6, 3.1) 0.1 (0.0, 0.9) 0.3 (0.1, 1.0

Ua 1.0 (0.6, 1.5) 0.9 (0.6, 1.4) 0.7 (0.5, 1.2) 0.2 (0.1, 0.4) 0.0 0.0 (0.0, 0.2

Ra 1.7 (1.1, 2.6) 1.3 (0.8, 2.2) 1.1 (0.6, 1.9) 0.5 (0.2, 1.3) 0.2 (0.1, 0.4) 0.1 (0.0, 0.6

3

Pa 4.4 (2.9, 6.5) 3.6 (2.3, 5.5) 2.8 (1.8, 4.5) 1.3 (0.6, 2.8) 0.4 (0.2, 0.8) 0.5 (0.1, 1.6

L a 0.7 (0.4, 1.3) 0.6 (0.3, 1.1) 0.5 (0.2, 1.1) 0.1 (0.0, 0.3) 0.2 (0.0, 0.5) 0.0

U a 0.3 (0.1, 1.2) 0.3 (0.1, 1.2) 0.3 (0.1, 1.2) 0.0 0.0 0.0

C a 0.3 (0.1, 1.5) 0.2 (0.0, 1.6) 0.2 (0.0, 1.6) 0.0 0.0 0.0

Maa/Pa 0.6 (0.1, 2.3) 0.6 (0.1, 2.3) 0.6 (0.1, 2.3) 0.0 0.0 0.0

O W 0.0 0.0 0.0 0.0 0.0 0.0S/Sa 0.6 (0.3, 1.3) 0.6 (0.3, 1.3) 0.6 (0.3, 1.2) 0.1 (0.0, 0.5) 0.0 0.0

Fa 2.3 (1.4, 3.8) 1.7 (1.0, 3.1) 1.5 (0.8, 2.9) 0.6 (0.2, 2.0) 0.3 (0.1, 0.6) 0.3 (0.1, 1.1

F/F 7.8 (2.3, 23.2) 7.8 (2.3, 23.2) 7.8 (2.3, 23.2) 4.1 (1.0, 15.3) 0.0 0.0

C/M 1.0 (0.1, 6.8) 1.0 (0.1, 6.8) 1.0 (0.1, 6.8) 0.0 0.0 0.0

P/D 0.3 (0.0, 2.1) 0.0 0.0 0.0 0.3 (0.0, 2.1) 0.0

O 1.3 (0.3, 5.2) 1.3 (0.3, 5.2) 1.3 (0.3, 5.2) 0.0 0.0 0.0

N: C a a aa( a a) .1

I aa a a a.2

I , a, a a a .3 Ea a 25+ a.

4.4 C

8/17/2019 repNTI

32/162

32

T 45 a aa a . I V Na a a

a , a , a, a a. Ca a a: aa a a

a a.

T a a a a a 19.9% (39.7% a a; 1.2% a

a). T a a a aa a (a: 19.5%; a: 39.1%;

a: 1.2%). T a a a a a 1.1% (1.9% a a; 0.4% a

a). T a a a a 6.4% (13.0% a a; 0.1% a a). U a (.., , a) a 0.1%.

B a, a aa a a 2544 a (24.9%),

a a a a a 65 a (1.9%) a 4564 (1.8%). T

a a a a 4564 (9.4%).

B , a a aa a a a aa (21.9%) a

a aa (18.5%). I a, a a a a a a aa (1.4%) a

a aa (0.4%). P a aa a (8.1%) a a aa (2.5%).

W aa a a a a, a

a a, a a a a a (a: 3.3%; a:

7.1%; a: 1.3%).

T a a a aa . W

aa a a a a C/M

(56.8% a 21.1%, ), a a a a a

F/F (4.9%). H, a a aa a.

8/17/2019 repNTI

33/162

33

T 46 a a a a , a

a aa. T a a a a a

a 15.3 . T aa a a a a a a a

12.5 a 772,000, . T a a a a 4.1

.

8/17/2019 repNTI

34/162

34

T 46: N ≥15 ,

GATS V N, 2010.

T CD

C

A

A 1 M H W P

O

2

O 15,294 12,795 12,542 722 4,117 92 A ()

1524 2,217 1,987 1,987 57 493 0

2544 7,757 6,756 6,700 289 1,937 47

4564 4,467 3,427 3,309 267 1,420 35

65+ 854 625 547 110 268 9

Ua 4,591 4,348 4,311 83 494 21

Ra 10,703 8,446 8,230 640 3,623 71

3

Pa 3,008 2,486 2,309 413 625 48

L a 7,466 5,997 5,922 251 2,452 21

U a 1,861 1,634 1,634 0 454 18

C a 742 689 689 2 94 4

Maa/Pa 881 843 843 2 104 2

O W 127 126 126 0 0 0

S/Sa 1,823 1,667 1,660 27 330 9

Fa 6,658 5,198 5,044 482 2,179 67

F/F 486 434 414 42 52 0

C/M 1,588 1,386 1,386 43 514 4

P/D 1,940 1,708 1,705 26 402 9

O 445 386 377 11 122 0

M 14,817 12,405 12,221 588 4,069 54

A ()

1524 2,195 1,965 1,965 39 493 0

2544 7,632 6,668 6,620 263 1,916 28

4564 4,239 3,236 3,145 224 1,397 27

65+ 752 536 491 62 264 0

Ua 4,493 4,255 4,234 63 494 16

Ra 10,324 8,150 7,987 525 3,575 38

3

Pa 2,655 2,200 2,080 309 597 10

L a 7,376 5,927 5,863 239 2,432 21

U a 1,853 1,626 1,626 0 454 18

C a 737 685 685 2 94 4

Maa/Pa 874 836 836 2 104 2

8/17/2019 repNTI

35/162

35

T CD

C

A

A 1 M H W P

O

2

O W 127 126 126 0 0 0

S/Sa 1,789 1,633 1,629 20 330 9

Fa 6,389 4,994 4,867 414 2,146 31

F/F 467 415 396 32 52 0

C/M 1,586 1,384 1,384 43 514 4

P/D 1,933 1,708 1,705 26 394 9

O 438 379 369 11 122 0

F 477 390 321 134 48 37

A ()

1524 22 22 22 18 0 0

2544 125 89 80 26 21 20

4564 228 190 164 43 23 9

65+ 102 89 56 47 4 9

Ua 98 93 77 19 0 5

Ra 379 297 244 115 48 33

3

Pa 353 286 229 104 28 37

L a 90 70 59 11 20 0

U a 8 8 8 0 0 0

C a 5 4 4 0 0 0

Maa/Pa 7 7 7 0 0 0

O W 0 0 0 0 0 0S/Sa 34 34 31 7 0 0

Fa 269 204 177 69 33 36

F/F 19 19 19 10 0 0

C/M 2 2 2 0 0 0

P/D 8 0 0 0 8 0

O 8 8 8 0 0 0

N: C a a aa( a a) .1I aa a a a.2I , a, a a a.3 Ea a 25+ a.

8/17/2019 repNTI

36/162

36

4.5 F

T 47 a a a aa a, a ,

aa a .

T a a 15 a a , aa a 19.5%, 4.3%

a 76.2%, . T a a a a a 38.7% a a a a 1.2%. T

a aa a a a 8.1% a a a a 0.2%. A 52.6% a a 98.6%

a .

B a , a a a a 4564 a (26.5%), 2544

a (23.3%) a a a a a 524 (9.3%). T a aa

a 2544 a (5.5%) a a a a a 65 a (2.7%). T a

a a .

B aa , a a a a a a a a

(24.9%) a a a a (15.7%). I a, a aa

a a a a (5.8%) a a a a

(2.4%).

B a, a a a a a F/F a C/M (54.8% a 54.7%, ) a a O W (9.2%). T a aa

a a C/M (10.4%) a a F/F (1.2%).

8/17/2019 repNTI

37/162

37

T 47: P ≥15 , ,

GATS V N, 2010.

S FD

C D O1 N T

(95% )

O 19.5 (18.4, 20.5) 4.3 (3.8, 4.9) 76.2 (75.1, 77.3) 100 A ()

1524 9.3 (7.7, 11.3) 4.0 (2.9, 5.5) 86.7 (84.4, 88.7) 100

2544 23.3 (21.7, 24.9) 5.5 (4.7, 6.5) 71.2 (69.4, 72.9) 100

4564 26.5 (24.4, 28.6) 3.2 (2.5, 4.0) 70.3 (68.1, 72.5) 100

65+ 12.3 (10.3, 14.8) 2.7 (1.9, 3.9) 85.0 (82.4, 87.2) 100

Ua 19.0 (17.8, 20.4) 4.2 (3.6, 5.0) 76.7 (75.3, 78.1) 100

Ra 19.6 (18.2, 21.1) 4.4 (3.7, 5.1) 76.0 (74.4, 77.5) 100

2

Pa 21.9 (19.5, 24.5) 2.4 (1.8, 3.3) 75.7 (73.1, 78.2) 100

L a 24.9 (23.2, 26.6) 4.9 (4.1, 5.9) 70.2 (68.4, 71.9) 100

U a 21.7 (18.7, 25.0) 5.7 (4.2, 7.6) 72.6 (69.1, 75.9) 100

C a 15.7 (13.4, 18.3) 5.8 (4.3, 7.8) 78.5 (75.5, 81.2) 100

Maa/Pa 19.8 (15.8, 24.4) 8.5 (6.1, 11.6) 71.8 (66.9, 76.1) 100

O W 9.2 (5.8, 14.3) 4.7 (2.1, 10.2) 86.1 (79.9, 90.6) 100

S/Sa 16.6 (14.4, 19.0) 3.7 (2.6, 5.2) 79.7 (77.1, 82.1) 100

Fa 23.7 (21.8, 25.8) 4.9 (4.0, 6.0) 71.4 (69.3, 73.4) 100

F/F 54.8 (43.5, 65.6) 1.2 (0.4, 4.0) 44.0 (33.2, 55.3) 100

C/M 54.7 (48.3, 60.9) 10.4 (6.4, 16.4) 35.0 (29.0, 41.4) 100

P/D 25.0 (21.6, 28.8) 7.0 (5.1, 9.5) 68.0 (63.9, 71.8) 100

O 31.1 (24.1, 39.0) 3.9 (1.9, 7.8) 65.0 (57.2, 72.1) 100

M 38.7 (36.9, 40.6) 8.7 (7.6, 9.8) 52.6 (50.6, 54.6) 100

A ()

1524 18.4 (15.2, 22.0) 7.7 (5.5, 10.7) 73.9 (69.8, 77.6) 100

2544 45.9 (43.1, 48.6) 10.8 (9.2, 12.6) 43.3 (40.5, 46.2) 100

4564 53.1 (49.7, 56.5) 6.4 (4.9, 8.2) 40.5 (37.2, 44.0) 100

65+ 26.7 (22.4, 31.5) 6.6 (4.5, 9.5) 66.7 (61.6, 71.5) 100

Ua 39.1 (36.8, 41.5) 8.6 (7.4, 10.1) 52.3 (49.8, 54.7) 100

Ra 38.6 (36.1, 41.1) 8.7 (7.3, 10.3) 52.7 (50.1, 55.4) 100

2

Pa 55.1 (50.4, 59.7) 6.3 (4.6, 8.7) 38.6 (34.2, 43.3) 100

L a 48.0 (45.2, 50.8) 9.3 (7.7, 11.2) 42.7 (39.9, 45.5) 100

U a 38.7 (33.9, 43.7) 10.2 (7.6, 13.5) 51.1 (46.0, 56.2) 100

C a 29.0 (25.1, 33.2) 10.7 (8.0, 14.3) 60.3 (55.6, 64.8) 100

Maa/Pa 32.1 (26.2, 38.8) 13.9 (10.0, 19.0) 53.9 (47.3, 60.4) 100

8/17/2019 repNTI

38/162

38

S FD

C D O1 N T

(95% )

O W 22.5 (14.3, 33.5) 11.6 (5.3, 23.4) 66.0 (54.0, 76.2) 100

S/Sa 40.8 (36.0, 45.8) 9.1 (6.5, 12.8) 50.0 (45.0, 55.0) 100

Fa 45.8 (42.6, 49.0) 9.5 (7.7, 11.7) 44.7 (41.5, 48.0) 100

F/F 72.8 (59.0, 83.2) 1.7 (0.5, 5.6) 25.5 (15.2, 39.6) 100

C/M 58.6 (51.8, 65.2) 11.0 (6.8, 17.4) 30.3 (24.4, 37.0) 100

P/D 43.5 (37.8, 49.4) 11.8 (8.7, 16.0) 44.7 (38.9, 50.6) 100

O 56.3 (46.4, 65.7) 6.6 (3.1, 13.7) 37.0 (28.0, 47.1) 100

F 1.2 (0.8, 1.8) 0.2 (0.1, 0.4) 98.6 (97.9, 99.0) 100

A ()

1524 0.1 (0.0, 0.5) 0.1 (0.0, 1.0) 99.7 (98.6, 100.0) 100

2544 0.7 (0.3, 1.3) 0.3 (0.1, 0.7) 99.1 (98.3, 99.5) 100

4564 2.6 (1.8, 3.7) 0.3 (0.1, 0.7) 97.1 (95.9, 98.0) 100

65+ 2.9 (1.5, 5.3) 0.1 (0.0, 0.7) 97.0 (94.6, 98.4) 100

Ua 0.7 (0.5, 1.2) 0.2 (0.1, 0.5) 99.0 (98.5, 99.4) 100

Ra 1.4 (0.9, 2.3) 0.2 (0.1, 0.5) 98.3 (97.4, 98.9) 100

2

Pa 4.1 (2.7, 6.2) 0.3 (0.1, 0.9) 95.6 (93.5, 97.1) 100

L a 0.4 (0.2, 0.9) 0.3 (0.1, 0.8) 99.3 (98.7, 99.6) 100

U a 0.2 (0.0, 1.4) 0.1 (0.0, 0.5) 99.7 (98.8, 99.9) 100

C a 0.2 (0.0, 1.6) 0.0 (0.0, 0.3) 99.7 (98.5, 99.9) 100

Maa/Pa 0.6 (0.1, 2.3) 0.0 99.4 (97.7, 99.9) 100

O W 0.0 0.0 100.0 100S/Sa 0.5 (0.2, 1.2) 0.1 (0.0, 0.3) 99.4 (98.7, 99.7) 100

Fa 2.0 (1.2, 3.3) 0.3 (0.1, 1.0) 97.7 (96.2, 98.6) 100

F/F 7.8 (2.3, 23.2) 0.0 92.2 (76.8, 97.7) 100

C/M 0.0 1.0 (0.1, 6.8) 99.0 (93.2, 99.9) 100

P/D 0.0 0.3 (0.0, 2.1) 99.7 (97.9, 100.0) 100

O 0.7 (0.1, 4.6) 0.7 (0.1, 4.7) 98.7 (94.8, 99.7) 1001Oaa a a .2 Ea a 25+ a .

8/17/2019 repNTI

39/162

39

4.6 N

T 48 aa a a a (aa a a)

a a a . T a a a a a a a 13.5

a, 13.6 a, a 10.9 a.

A a a , 11.8% 5 a a, 19.2% 59 a a, 32.1% 1014 a/a, 7.6% 1519 a a a 29.3% a 20 a a.

Ma a a a a a a a a a . A a

a , 32.3% a a 26.3% a 1014 a/a, 7.8% a a 1.2% a

1519 a a a, a 29.5% a a 22.5% a a 20 a a a.

T a a a a 20 a a a 14% 1524

a 31.3% 2544 a , a 34.1% 4564 a , a 22.1% a 65

a .

T a a a a a . T

a a 1014 a a (a: 34.2%; a: 31.0%) a

a a 1519 a a (a: 6.6%; a: 8.1%).

B a, a a a 20 a a a a

a a (36.3%) a a a a (17.4%).

B a, a a a 20 a a a a

F/F (41.9%) a a Maa/Pa (21.8%).

8/17/2019 repNTI

40/162

8/17/2019 repNTI

41/162

8/17/2019 repNTI

42/162

C a

Maa/Pa

O W

S/Sa

Fa 10.8 (8.6, 12.9) 24.9 (12.6, 43.2) 20.8 (9.6, 39.3) 34.1 (20.3, 51.2) 0.0

F/F

C/M

P/D

O 1 A a a . Ca aa a a.

2 Ea a 25+ a .

Ia a a a 25 a a a .

8/17/2019 repNTI

43/162

43

4.7 A

T 49 aa a a a a a (a) a a

a 20 a 34. T a a a a a 19.0.

T a a a a a a 20 a (44.0%),

a a a 17 19 (35.9%). T a a a a a 15 a a

(6.8%). A a a a a a 2034 a a , a a

a a a a a a a a 25 a. T a

a a a a .

T 49: A 2034 ,

GATS V N, 2010.

D A D S I ()1

D

C

A A

D S

I ()1

8/17/2019 repNTI

44/162

44

T 410: P , , ≥15 ,

GATS V N, 2010.

D

C

F S1

(A A A)

F S1

(A E D

S)2

F S1

(A E S)3

(95% )

O 6.4 (5.8, 7.1) 23.5 (21.4, 25.7) 29.3 (27.2, 31.4)

Ma 12.7 (11.5, 14.0) 23.3 (21.2, 25.5) 28.8 (26.7, 31.0)

Fa 0.5 (0.3, 0.8) 28.6 (18.8, 40.9) 41.6 (30.9, 53.1)

A ()

1524 0.7 (0.3, 1.5) 6.4 (3.0, 13.4) 17.5 (12.5, 23.9)

2544 5.9 (5.0, 6.9) 18.8 (16.2, 21.6) 25.3 (22.7, 28.2)

4564 10.5 (9.1, 12.0) 27.3 (24.1, 30.8) 32.5 (29.3, 35.8)

65+ 15.3 (12.7, 18.3) 52.5 (45.9, 59.0) 55.8 (49.7, 61.7)

Ua 6.1 (5.3, 6.9) 22.6 (20.1, 25.3) 28.3 (25.7, 31.0)

Ra 6.6 (5.8, 7.5) 23.9 (21.2, 26.8) 29.7 (27.0, 32.5)

4

Pa 5.8 (4.7, 7.3) 20.2 (16.3, 24.8) 25.1 (21.1, 29.6)

L a 9.1 (8.0, 10.3) 25.3 (22.6, 28.2) 30.5 (27.8, 33.3)

U a 10.1 (8.0, 12.6) 29.8 (24.1, 36.3) 35.6 (30.0, 41.6)

C a 10.0 (8.2, 12.1) 35.1 (29.5, 41.1) 42.5 (37.0, 48.1)

Maa/Pa 10.8 (8.2, 14.0) 32.0 (24.6, 40.5) 38.3 (31.1, 45.9)

O W 9.7 (5.5, 16.6) 44.7 (28.3, 62.4) 49.4 (35.1, 63.8)

S/Sa 6.7 (5.2, 8.5) 27.3 (21.9, 33.5) 33.3 (28.1, 39.0)

Fa 6.8 (5.9, 8.0) 21.3 (18.5, 24.4) 26.7 (23.8, 29.8)

F/F 3.6 (1.4, 8.7) 6.0 (2.4, 14.3) 11.1 (5.7, 20.7)

C/M 7.4 (4.7, 11.4) 11.0 (7.1, 16.7) 15.9 (11.2, 22.2)P/D 4.5 (3.2, 6.4) 14.0 (10.0, 19.2) 21.5 (16.9, 27.0)

O 5.3 (2.4, 11.1) 13.4 (6.3, 26.3) 15.9 (8.5, 27.7)1 C .2 A a a a .3 A a a .4 Ea a 25+ a .

4.9 T

T 411 a a a 15 a a aa. T

a a a a ( a a a aa a

a ) a 25.2%. Ca , a a

a (48.0%) 13 a a (3.6%).

B a, 4564 a (31.0%) a 2544 a (29.3%) a a a 1524

(13.6%). T a a a 25.7% a aa a 24.1% a aa. P

a a (30.8%) a a a (29.1%) a a

a a (22.0%). B a, a a a a

C/M (65.5%), F/F (60.1%). T a a

a a a O W (14.3%).

8/17/2019 repNTI

45/162

45

T a a a: , a ; a .

Va a a (94.7%). T a a

a a a 4.8% a 0.5%, . T

a a a a a a (59.8%), a

65 a (38.7%), a aa (6.1%), a a a (15.7%).

T 411: P ≥15 ,

GATS V N, 2010.

T C T U

D

C

C T

U1 S S

B

T

(95% )

O 25.2 (24.0, 26.4) 94.7 (93.3, 95.9) 4.8 (3.7, 6.2) 0.5 (0.2, 1.1) 100

Ma 48.0 (46.0, 50.0) 99.4 (98.9, 99.6) 0.4 (0.2, 0.8) 0.2 (0.1, 0.6) 100

Fa 3.6 (2.9, 4.5) 36.6 (27.7, 46.6) 59.8 (48.5, 70.1) 3.5 (1.0, 11.4) 100

A ()

1524 13.6 (11.5, 15.9) 100.0 0.0 0.0 100

2544 29.3 (27.5, 31.1) 98.7 (97.4, 99.4) 0.8 (0.3, 2.0) 0.5 (0.2, 1.4) 100

4564 31.0 (28.8, 33.2) 95.4 (92.8, 97.1) 3.7 (2.2, 6.2) 0.9 (0.3, 2.4) 100

65+ 24.5 (21.4, 27.9) 61.3 (53.4, 68.5) 38.7 (31.5, 46.6) 0.0 100

Ua 24.1 (22.7, 25.6) 98.1 (96.9, 98.8) 1.6 (0.9, 2.7) 0.3 (0.1, 1.1) 100

Ra 25.7 (24.1, 27.3) 93.3 (91.4, 94.9) 6.1 (4.6, 8.1) 0.6 (0.2, 1.4) 100

2

Pa 29.1 (26.5, 31.7) 83.1 (78.5, 86.9) 15.7 (11.9, 20.4) 1.2 (0.3, 4.1) 100

L a 30.8 (29.0, 32.6) 97.0 (95.3, 98.2) 2.6 (1.6, 4.4) 0.3 (0.1, 1.1) 100

U a 27.6 (24.3, 31.1) 99.7 (97.9, 100.0) 0.3 (0.0, 2.1) 0.0 100

C a 22.0 (19.2, 25.1) 97.7 (93.6, 99.2) 0.9 (0.3, 2.8) 1.4 (0.3, 6.6)

100

Maa/Pa 28.5 (24.1, 33.4) 100.0 0.0 0.0 100

O W 14.3 (9.7, 20.6) 100.0 0.0 0.0 100

S/Sa 20.8 (18.4, 23.5) 98.7 (97.0, 99.5) 1.2 (0.5, 2.9) 0.1 (0.0, 0.9) 100

Fa 30.0 (27.9, 32.1) 94.8 (92.6, 96.4) 4.4 (2.9, 6.6) 0.8 (0.3, 2.0) 100

F/F 60.1 (49.4, 70.0) 98.6 (94.4, 99.6) 1.4 (0.4, 5.6) 0.0 100

C/M 65.5 (59.0, 71.4) 100.0 0.0 0.0 100

P/D 32.4 (28.5, 36.6) 99.5 (98.0, 99.9) 0.5 (0.1, 2.0) 0.0 100

O 35.1 (28.0, 42.9) 97.0 (89.0, 99.2) 0.3 (0.0, 2.0) 2.7 (0.6, 11.2) 1001 I a a aa ( a a) .2 Ea a 25+ a .

4.10 T

O a aa a a a a

a. T 412 a. T a a a

a 630 a a (47.1%), a a 5

(19.1%). P 4564 a (23.1%) a a

8/17/2019 repNTI

46/162

46

1524 a (9.0%). Ca a, a a a a

(10.7%) a a.

T 412: P ≥15 ,

GATS V N, 2010.

T D

C ≤5 630 3160 >60 T

(95% )

O 19.1 (17.0, 21.4) 47.1 (44.2, 50.0) 15.0 (13.1, 17.2) 18.8 (16.7, 21.1) 100

Ma 19.1 (16.9, 21.5) 47.2 (44.3, 50.2) 15.0 (13.0, 17.2) 18.7 (16.5, 21.1) 100

Fa 17.7 (10.5, 28.3) 42.5 (30.0, 56.1) 17.3 (9.2, 30.2) 22.4 (15.8, 30.9) 100

A ()

1524 9.0 (5.2, 15.1) 51.8 (41.7, 61.8) 18.5 (12.4, 26.7) 20.7 (13.7, 30.1) 100

2544 18.8 (15.9, 22.2) 48.6 (44.7, 52.6) 13.8 (11.4, 16.8) 18.7 (15.8, 22.0) 100

4564 23.1 (19.4, 27.2) 43.6 (39.0, 48.2) 16.1 (12.8, 19.9) 17.3 (14.0, 21.2) 100

65+ 21.1 (14.3, 30.0) 42.7 (33.5, 52.5) 12.4 (7.3, 20.5) 23.7 (16.9, 32.3) 100

Ua 15.4 (12.9, 18.2) 42.4 (38.7, 46.2) 20.1 (16.9, 23.6) 22.1 (19.0, 25.7) 100

Ra 20.7 (17.9, 23.8) 49.1 (45.3, 52.9) 12.9 (10.5, 15.7) 17.4 (14.7, 20.4) 100

1

Pa 22.6 (17.8, 28.2) 52.8 (46.6, 58.9) 10.8 (7.6, 15.1) 13.9 (10.5, 18.2) 100

L a 19.8 (16.8, 23.3) 45.9 (41.9, 49.9) 15.3 (12.6, 18.5) 19.0 (15.9, 22.4) 100

U a 23.1 (17.2, 30.4) 40.3 (32.7, 48.4) 15.3 (10.6, 21.5) 21.3 (15.7, 28.2) 100

C a 10.7 (6.4, 17.3) 36.8 (29.0, 45.3) 23.3 (16.7, 31.4) 29.3 (22.0, 37.8) 100

Maa/Pa 11.9 (6.1, 21.9) 42.3 (30.1, 55.5) 24.3 (16.4, 34.5) 21.5 (14.4, 30.8) 100

O W

S/Sa 14.8 (10.6, 20.4) 48.5 (40.9, 56.1) 19.2 (14.0, 25.6) 17.5 (12.3, 24.3) 100

Fa 21.3 (17.8, 25.3) 50.2 (45.7, 54.8) 11.3 (8.8, 14.4) 17.2 (14.1, 20.7) 100

F/F 27.5 (15.0, 44.8) 58.9 (42.7, 73.3) 6.4 (2.5, 15.4) 7.2 (2.3, 20.4) 100

C/M 14.1 (9.0, 21.3) 44.8 (36.2, 53.7) 20.3 (13.8, 28.8) 20.9 (13.6, 30.7) 100

P/D 18.5 (13.5, 24.9) 38.6 (31.3, 46.4) 16.4 (11.7, 22.5) 26.5 (20.5, 33.4) 100

O 16.8 (8.9, 29.7) 43.6 (28.5, 59.9) 15.7 (6.7, 32.5) 23.8 (12.7, 40.3) 1001 Ea a 25+ a .

Ia a a a 25 a a a .

8/17/2019 repNTI

47/162

47

5. S S

5.1 E S S W

Pa a (SHS) a a a a 15 a

a a a a 30 a. T

a a 3.

3 N a a a , a aa a a

aa, a a a .

8/17/2019 repNTI

48/162

48

T 51 a, V Na, 55.9% a ( a 8 ) a SHS a

30 a. C , a SHS a a

49.0% (a a 5 ).

A a , a (68.7%) a a (41.4%) a SHS a . T

a a a (45.6%) SHS a a a.

P a Maa/Pa (44.4%), O W (44.7%) a P/D (48.5%)

a SHS a a C/M (81.8%), Fa(69.9%), S/Sa (63.9%).

T a SHS a a a a . Ma (62.8%)

a a (41.3%) SHS a . T a a a (41.1%)

SHS a a a. P a Maa/Pa (38.8%), O

W (42.3%) a P/D (39.0%) SHS a a

C/M (78.3%), Fa (62.5%), S/Sa (60.5%).

8/17/2019 repNTI

49/162

49

T 51: P ≥15 ,

GATS V N, 2010.

A E T S W1 D

C O N

(95% )

(95% )

O 55.9 (52.8, 59.0) 7,997.1 49.0 (45.5, 52.6) 5,113.4

Ma 68.7 (64.9, 72.2) 5,225.9 62.8 (57.1, 68.1) 2,359.2

Fa 41.4 (37.2, 45.7) 2,771.2 41.3 (37.1, 45.6) 2,754.2

A ()

1524 49.2 (41.8, 56.7) 1,796.5 45.7 (37.9, 53.7) 1,380.4

2544 58.0 (54.4, 61.6) 4,593.0 50.4 (46.1, 54.6) 2,805.3

4564 58.6 (53.6, 63.5) 1,554.5 50.3 (44.2, 56.3) 890.8

65+ 59.0 (36.8, 78.0) 53.2

Ua 52.4 (49.1, 55.7) 3,539.9 45.1 (41.3, 49.0) 2,232.5

Ra 59.0 (53.9, 64.0) 4,457.2 52.6 (46.7, 58.5) 2,880.9

2

Pa 66.1 (54.9, 75.7) 605.6 59.6 (46.5, 71.4) 363.4

L a 61.1 (56.3, 65.7) 2,947.2 51.2 (45.1, 57.2) 1,586.6

U a 61.6 (55.7, 67.2) 1,549.1 55.8 (48.8, 62.5) 998.6

C a 45.6 (41.1, 50.2) 1,096.3 41.1 (36.4, 46.0) 782.0

Maa/Pa 44.4 (39.1, 49.8) 1,203.8 38.8 (33.1, 44.7) 780.2

O W 44.7 (35.8, 54.1) 370.1 42.3 (32.7, 52.6) 299.7

S/Sa 63.9 (58.7, 68.8) 2,039.1 60.5 (54.6, 66.0) 1,507.8Fa 69.9 (60.9, 77.5) 991.6 62.5 (51.4, 72.4) 611.0

F/F 70.8 (45.2, 87.7) 167.4

C/M 81.8 (69.9, 89.7) 764.2 78.3 (62.4, 88.7) 277.9

P/D 48.5 (41.8, 55.4) 1,666.3 39.0 (31.3, 47.1) 956.1

O 50.9 (38.6, 63.0) 295.7 40.5 (27.9, 54.4) 171.21 I a 30 a. A a

a .2 Ea a 25+ a .

Ia a a a 25 a a a .

8/17/2019 repNTI

50/162

50

5.2 SHS

T 52 a SHS a a a a 30 a. I V Na, 73.1%

a a 15 a a ( a 47 ) a SHS a a a .

C , a SHS a a 67.6% (a a 33

).

Oa, a (77.2%) a a a SHS a a a (69.2%). B a, a SHS a a a a 1524 (75.9%) a 2544 (74.7%); a a a a

65 a a (62.7%). B , a aa (77.4%) a a aa

(63.3%) SHS a . B a, a a a a a a

SHS a (77.8%) a a a a a (50.6%). B a,

F/F (87.6%), C/M (83.0%), a Fa (80.0%)

SHS a a a Maa/Pa (56.6%) O W (61.3%).

A , SHS a a a a. T a SHS a

a a a 1524 (74.2%) a a a a 65 a a (57.2%). B ,

a aa (72.0%) a a aa (57.7%). B a, a

a a (71.5%) a a a SHS a a

a (57.2%) a a. B a, F/F (77.5%) a a (73.5%) a

a SHS a , Maa/Pa a a a (48.3%).

8/17/2019 repNTI

51/162

51

T 52: P ≥15 ,

GATS V N, 2010.

A E T S H1 D

C O N

(95% )

(95% )

O 73.1 (71.7, 74.5) 46,774 67.6 (65.9, 69.2) 32,943

Ma 77.2 (75.5, 78.9) 24,021 65.2 (62.3, 67.9) 10,650

Fa 69.2 (67.4, 71.0) 22,752 68.8 (67.0, 70.6) 22,293

A ()

1524 75.9 (73.1, 78.5) 12,553 74.2 (71.2, 77.0) 10,644

2544 74.7 (72.9, 76.3) 20,025 68.2 (66.1, 70.4) 13,015

4564 71.2 (69.1, 73.2) 10,664 62.1 (59.4, 64.7) 6,541

65+ 62.7 (59.0, 66.3) 3,532 57.2 (53.1, 61.3) 2,743

Ua 63.3 (61.1, 65.5) 12,416 57.7 (55.2, 60.2) 8,676

Ra 77.4 (75.7, 79.1) 34,358 72.0 (69.9, 74.0) 24,267

2

Pa 77.8 (75.2, 80.1) 9,562 71.5 (68.5, 74.4) 6,655

L a 74.3 (72.5, 76.1) 18,504 66.8 (64.4, 69.0) 11,646

U a 64.7 (61.2, 67.9) 4,386 56.6 (52.5, 60.7) 2,789

C a 50.6 (46.9, 54.3) 1,736 43.7 (39.7, 47.8) 1,176

Maa/Pa 56.6 (51.9, 61.2) 1,767 48.3 (42.9, 53.7) 1,081

O W 61.3 (52.8, 69.1) 561 58.3 (48.7, 67.2) 459

S/Sa 71.9 (69.0, 74.7) 6,438 68.9 (65.7, 71.9) 4,908

Fa 80.0 (78.0, 81.8) 18,506 73.5 (71.0, 75.9) 12,147

F/F 87.6 (80.4, 92.4) 756 77.5 (62.7, 87.5) 292

C/M 83.0 (77.7, 87.3) 2,019 66.2 (55.4, 75.5) 558

P/D 74.2 (70.0, 78.0) 4,478 67.8 (62.4, 72.8) 2,778

O 72.6 (65.5, 78.8) 906 63.0 (53.5, 71.6) 5131 A a a, , .2 Ea a 25+ a .

8/17/2019 repNTI

52/162

52

5.3 SHS

T GATS a a a a a 30 a a a

a. N a a a a a SHS .

a a a a 30 a. T SHS a

Ba/Ca/Ta (89.4%), aa (80.7%). Haa a (21.6%) a (23.1%) a

a SHS. T a a SHS a U a G 55.6% a 34.8%, . T a SHS a a a

a a a , a, a 1524 a .

8/17/2019 repNTI

53/162

53

Ta 53 a SHS a. A a a a a

30 a, a a SHS Ba/Ca/Ta (92.6%), aa

(84.9%). E SHS a aa a (23.6%) a (22.3%). T a a

SHS a U a G 54.3% a 38.7%, . T a SHS

a a a, a, .

T a a a a a a a 30 a. T

SHS a Ba/Ca/Ta (89.4%), aa (80.7%). Haa a

(21.6%) a (23.1%) a a SHS. T a a SHS a

U a G 55.6% a 34.8%, . T a SHS a

a a a a a , a, a 1524 a .

8/17/2019 repNTI

54/162

8/17/2019 repNTI

55/162

8/17/2019 repNTI

56/162

56

6. C

6.1 I

I GATS a a a a a

a , 12 , a.

8/17/2019 repNTI

57/162

57

T 61 a . T a W a, 12

a (38.2%), a N (30.4%). T

T a 12 (19.8%), Pa (9.5%) a D

(2.1%). Oa, 67.5% a a .

T a a a a a a (Pa

: 9.6% . 5.3%, T a 12 :20% . 14.1%; W

a, 12 :38.9% . 17.5%). I, a a a a a a (N : 46.5% .29.9% a D :

16.7% . 1.7%).

W a a , a a a a

, a (6.1% . 9.6%14.4%); 12

(11.6% . 19.1%29.7%), W a 12 (34.9%41.2%). I,

a a a (41.7%)

(5.6%).

B a, 5.3% , 20.4% 33.9%

aa a . O T a

12 (35.5%) a W a 12 (53.3%); a W a 12 N . T a

a a a aa a a .

8/17/2019 repNTI

58/162

58

T 61: P ≥15

GATS V N, 2010.

I Q S1

D

C

P Q

W N

M

T A

Q W N

12 M

W Q S,

B N N

12 M

N I

Q D K T

(95% )O 9.5 (8.2, 11.0) 19.8 (17.6, 22.1) 38.2 (35.6, 40.9) 30.4 (27.8, 33.1) 2.1 (1.4, 3.3) 10

Ma 9.6 (8.3, 11.2) 20.0 (17.8, 22.3) 38.9 (36.2, 41.5) 29.9 (27.3, 32.6) 1.7 (1.1, 2.4) 10

Fa 5.3 (2.1, 12.6) 14.1 (7.2, 25.7) 17.5 (10.3, 28.2) 46.5 (34.5, 58.9) 16.7 (6.7, 35.8) 10

A ()

1524 11.3 (7.1, 17.5) 22.7 (15.6, 31.8) 32.3 (25.1, 40.4) 31.0 (23.4, 39.9) 2.7 (1.2, 6.0) 10

2544 10.3 (8.3, 12.7) 19.4 (16.7, 22.4) 39.9 (36.5, 43.5) 28.5 (25.2, 32.0) 1.9 (1.1, 3.3) 10

4564 7.2 (5.4, 9.5) 20.3 (17.0, 24.0) 39.9 (35.8, 44.2) 31.0 (27.1, 35.2) 1.6 (0.8, 3.0) 10

65+ 9.5 (5.6, 15.8) 13.0 (8.3, 19.6) 28.5 (21.3, 37.0) 43.6 (35.1, 52.5) 5.4 (2.7, 10.6) 10

Ua 9.8 (7.9, 12.2) 15.9 (13.5, 18.6) 42.3 (38.8, 45.9) 30.3 (27.0, 34.0) 1.7 (1.0, 2.9) 10

Ra 9.4 (7.7, 11.3) 21.4 (18.6, 24.6) 36.4 (33.1, 39.9) 30.4 (27.1, 34.0) 2.3 (1.4, 4.0) 10 2

Pa 6.1 (3.9, 9.4) 11.6 (8.6, 15.6) 34.9 (29.5, 40.8) 41.7 (35.9, 47.8) 5.6 (3.1, 10.1) 10

L a 9.6 (7.8, 11.7) 19.1 (16.5, 22.1) 41.2 (37.9, 44.6) 28.9 (25.7, 32.3) 1.1 (0.6, 2.0) 10

U a 10.4 (6.6, 16.2) 29.7 (23.7, 36.4) 38.2 (31.9, 45.0) 20.9 (15.7, 27.3) 0.7 (0.2, 3.0) 10

C a 14.4 (9.7, 20.7) 25.5 (19.7, 32.2) 38.4 (31.8, 45.5) 21.8 (16.6, 27.9) 0.0 10

Maa/Pa 13.3 (8.4, 20.3) 29.0 (19.6, 40.6) 37.4 (28.8, 46.8) 20.4 (13.7, 29.3) 0.0 10

O W 5.9 (1.4, 21.3) 35.5 (17.0, 59.7) 53.3 (32.4, 73.2) 5.3 (1.7, 15.5) 0.0 10

S/Sa 9.5 (5.9, 15.1) 16.9 (12.3, 22.9) 40.1 (34.0, 46.6) 31.5 (25.4, 38.2) 2.0 (0.8, 5.0) 10

Fa 10.0 (7.9, 12.6) 19.4 (16.1, 23.3) 36.3 (32.2, 40.7) 31.3 (27.1, 35.8) 2.9 (1.6, 5.2) 10

F/F 5.0 (1.8, 13.0) 12.8 (5.7, 26.3) 48.1 (32.0, 64.6) 31.1 (17.5, 49.0) 3.0 (1.0, 9.3) 10

C/M 8.1 (4.1, 15.5) 20.1 (13.6, 28.6) 44.7 (37.2, 52.5) 26.3 (19.1, 35.0) 0.8 (0.2, 3.1) 10

P/D 8.3 (5.1, 13.2) 21.8 (16.5, 28.2) 38.6 (32.0, 45.6) 29.8 (23.7, 36.6) 1.5 (0.4, 5.6) 10

O 10.8 (4.7, 22.9) 15.8 (8.4, 27.7) 39.6 (26.2, 54.7) 33.9 (21.1, 49.6) 0.0 101A a a a .2 Ea a 25+ a .

6.2 T

T a a a a

a a .

T 62 a a a 15 a a. T a

a: a 1 a, 1 a a 5 a, 5 a a 10 a, a, 10 a .

A a a , a 10 a (43.5%) a a a a a (13.5%); 24. % a a

1 4 a a 18.5% a 5 9 a.

T a a a a a . F a a 65 a

a a a a 10 a (62.8%), a

1524 a a a 10 a.

8/17/2019 repNTI

59/162

59

T 62: P ≥15 ,

GATS V N, 2010.

T ()1 D

C

8/17/2019 repNTI

60/162

60

T 63 a a a a, a aa (HCP),

a a a a a HCP .

A a a a a a a 12 , 55.3% a

a a a 12 . T a 55.6% a a a 44.4% a a.

T a 1524 (60.5%) a ; a a a a a 47.7%

a a 65 a . S a a a (51.9%) a a (56.7%) aa a

. B a , a a a a a (46.1%),

a a a a aa . B a, O W

(66.7%) a , a F/F (41.1%).

V a aa a a (

8/17/2019 repNTI

61/162

61

T 63: P ≥15

12 , GATS V N, 2010.

S

D

C

M

1 V HCP

1,2

A HCP

2,3

A

HCP2,3

(95% )

O 55.3 (52.5, 58.0) 27.2 (25.0, 29.5) 34.9 (30.9, 39.1) 29.7 (25.8, 34.0)

Ma 55.6 (52.9, 58.3) 26.9 (24.7, 29.2) 35.3 (31.2, 39.7) 30.2 (26.1, 34.5)

Fa 44.4 (30.1, 59.6) 36.1 (25.2, 48.6) 25.6 (11.8, 46.7) 20.3 (8.1, 42.4)

A ()

1524 60.5 (51.6, 68.8) 26.3 (20.1, 33.7) 16.8 (8.7, 30.0) 14.9 (7.3, 28.2)

2544 55.2 (51.6, 58.7) 24.1 (21.3, 27.1) 32.5 (26.7, 38.8) 28.3 (22.7, 34.6)

4564 54.2 (49.9, 58.5) 28.6 (25.0, 32.5) 47.5 (40.2, 54.9) 39.6 (32.5, 47.1)

65+ 47.7 (39.4, 56.1) 49.8 (41.2, 58.3) 32.6 (22.8, 44.3) 27.3 (18.3, 38.6)

Ua 51.9 (48.4, 55.4) 30.3 (27.4, 33.4) 40.9 (35.2, 47.0) 33.8 (28.2, 39.8)

Ra 56.7 (53.0, 60.3) 25.9 (23.0, 28.9) 31.8 (26.7, 37.4) 27.7 (22.8, 33.4)

4

Pa 46.1 (40.1, 52.2) 28.4 (23.5, 34.0) 36.9 (28.2, 46.6) 28.9 (21.1, 38.1)

L a 56.2 (52.7, 59.6) 24.0 (21.2, 27.1) 33.3 (27.8, 39.4) 28.1 (22.8, 34.0)

U a 59.0 (52.3, 65.4) 33.1 (26.8, 40.1) 47.5 (34.9, 60.3) 45.9 (33.5, 58.9)

C a 56.2 (49.4, 62.8) 41.6 (34.9, 48.7) 47.1 (37.2, 57.2) 37.4 (28.0, 47.8)

Maa/Pa 60.3 (50.9, 68.9) 45.7 (36.9, 54.8) 34.0 (23.9, 45.8) 26.8 (18.0, 38.0)

O W 66.7 (46.8, 82.0) 40.0 (22.4, 60.6)

S/Sa 49.7 (42.5, 56.9) 23.5 (18.2, 29.8) 36.8 (24.3, 51.5) 29.2 (17.8, 44.0)

Fa 55.0 (50.4, 59.5) 25.7 (22.4, 29.4) 33.8 (27.1, 41.2) 29.9 (23.6, 37.0)

F/F 41.1 (27.3, 56.5) 26.8 (16.1, 41.2)

C/M 60.5 (51.6, 68.7) 21.7 (15.1, 30.2) 27.9 (16.7, 42.6) 25.4 (13.9, 42.0)

P/D 56.5 (49.7, 63.1) 25.0 (19.8, 31.0) 40.7 (28.7, 54.0) 35.1 (23.9, 48.1)

O 54.3 (39.8, 68.1) 20.8 (10.9, 36.1) 1 A a a a a 12 .2 HCP = aa .3 A a a a a 12 , a a HCP

a 12 .4 Ea a 25+ a .

Ia a a a 25 a a a .

8/17/2019 repNTI

62/162

62

6.4 C

T 64 a a a 12 a a a

(a

8/17/2019 repNTI

63/162

63

T 64: P ≥15 12 ,

GATS V N, 2010.

U C M1

D

C

N R

T2

P

M C/A O3

(95% )

O 24.4 (21.3, 27.8) 0.4 (0.1, 1.4) 3.0 (2.1, 4.4) 9.6 (7.8, 11.8)

Ma 24.6 (21.5, 28.1) 0.4 (0.1, 1.4) 3.0 (2.1, 4.5) 9.5 (7.7, 11.7)

Fa 16.3 (6.3, 35.9) 0.0 3.2 (0.5, 20.0) 13.1 (5.3, 28.8)

A ()

1524 37.2 (27.5, 48.0) 0.0 3.7 (1.3, 9.8) 6.4 (3.1, 12.9)

2544 25.3 (21.2, 30.0) 0.5 (0.1, 3.2) 2.5 (1.3, 4.8) 9.3 (6.9, 12.6)

4564 17.8 (13.6, 22.9) 0.4 (0.1, 1.4) 3.7 (2.2, 6.1) 11.8 (8.5, 16.1)

65+ 12.4 (6.8, 21.6) 0.8 (0.1, 5.3) 2.3 (0.6, 9.0) 9.6 (5.4, 16.7)

Ua 28.7 (24.6, 33.2) 1.1 (0.2, 4.9) 3.9 (2.3, 6.7) 11.6 (8.9, 15.0)

Ra 22.7 (18.8, 27.2) 0.1 (0.0, 0.8) 2.7 (1.6, 4.4) 8.8 (6.6, 11.6)

4

Pa 23.7 (16.8, 32.3) 0.5 (0.1, 3.6) 1.8 (0.6, 5.3) 6.8 (3.9, 11.7)

L a 22.1 (17.9, 26.9) 0.5 (0.1, 3.1) 3.0 (1.8, 5.0) 10.2 (7.8, 13.4)

U a 19.3 (13.4, 26.9) 0.4 (0.1, 3.0) 3.8 (1.4, 10.3) 11.6 (6.8, 19.1)

C a 22.4 (16.1, 30.3) 0.0 3.3 (1.3, 8.2) 16.9 (10.7, 25.6)

Maa/Pa 35.5 (23.2, 50.0) 0.0 3.0 (0.8, 10.4) 11.8 (6.9, 19.4)

O W

S/Sa 31.0 (22.5, 41.0) 2.1 (0.3, 13.6) 7.5 (3.6, 15.1) 10.4 (5.6, 18.3)Fa 19.6 (15.4, 24.5) 0.2 (0.0, 1.2) 2.3 (1.2, 4.4) 10.4 (7.6, 14.0)

F/F 46.1 (22.9, 71.1) 0.0 8.7 (2.0, 30.6) 10.3 (2.9, 30.6)

C/M 25.9 (16.5, 38.2) 0.0 2.8 (0.9, 7.8) 8.8 (4.0, 18.3)

P/D 31.3 (23.1, 40.8) 0.0 1.2 (0.3, 3.8) 7.6 (4.1, 13.6)

O 33.4 (16.4, 56.2) 0.0 0.0 5.8 (1.7, 18.1)1 A a a a a 12 a a a a 12 .2 N a a a a a .3 O aa , a, a a .4 Ea a 25+ a .

Ia a a a 25 a a a .

8/17/2019 repNTI

64/162

64

7. E

7.1 L

GATS V Na a a a a a a. T

a a Vaaa (11.6%), H (9.5%), Ba (9.2%), J (8.4%) a T (6.9%). O 5

a a a, Vaaa a T a a , J a H a V Na

(Ta 71). Vaaa a a a a a (15.9%), 1524 a (23.3%), a

a (19.6%) a (27.4%) a.

T 71: P ≥15 ,

GATS V N, 2010.

L D

C V H B J T

(95% )

O 11.6 (9.4, 14.2) 9.5 (7.5, 12.0) 9.2 (7.3, 11.6) 8.4 (6.6, 10.5) 6.9 (5.2, 9.0)

Ma 11.9 (9.7, 14.6) 9.7 (7.6, 12.3) 9.3 (7.3, 11.7) 8.5 (6.7, 10.7) 7.0 (5.3, 9.1)

Fa 0.0 2.0 (0.5, 8.2) 7.7 (2.6, 21.2) 3.2 (0.5, 16.8) 3.8 (0.8, 16.2)

A ()

1524 23.3 (16.2, 32.3) 13.1 (7.3, 22.4) 8.6 (4.3, 16.3) 13.7 (8.6, 21.1) 3.7 (1.2, 10.8)

2544 10.5 (7.9, 13.8) 9.3 (7.2, 12.1) 8.3 (6.1, 11.1) 8.3 (6.2, 11.0) 7.2 (5.2, 9.9)

4564 7.4 (5.3, 10.2) 7.7 (5.1, 11.5) 11.5 (8.5, 15.4) 5.0 (3.1, 8.1) 7.1 (4.7, 10.5)

65+ 7.1 (3.7, 13.4) 9.2 (3.9, 20.1) 10.7 (4.7, 22.4) 9.5 (4.9, 17.9) 13.7 (8.0, 22.4)

Ua 13.9 (10.8, 17.8) 9.6 (7.0, 13.2) 7.3 (5.5, 9.8) 11.2 (8.6, 14.4) 1.7 (0.9, 3.3)

Ra 10.4 (7.6, 14.0) 9.4 (6.8, 12.9) 10.3 (7.6, 13.7) 6.9 (4.8, 9.9) 9.6 (7.1, 12.8)

1

Pa 1.6 (0.5, 4.6) 11.6 (7.8, 17.0) 10.5 (7.0, 15.5) 6.1 (3.7, 9.8) 5.1 (2.9, 8.9)

L a 7.5 (5.4, 10.4) 8.2 (6.0, 11.1) 10.6 (8.0, 14.0) 9.1 (6.7, 12.2) 7.8 (5.7, 10.6)

U a 19.6 (13.7, 27.4) 7.7 (4.3, 13.3) 6.1 (3.4, 10.9) 3.5 (1.8, 6.8) 11.4 (7.1, 17.8)

C a 27.4 (20.4, 35.8) 7.3 (3.4, 14.9) 2.5 (0.9, 6.9) 5.3 (2.5, 10.8) 3.7 (1.8, 7.3)

Maa/Pa 26.0 (18.5, 35.2) 17.8 (9.0, 32.2) 1.0 (0.3, 3.0) 2.6 (1.0, 6.6) 2.1 (0.8, 5.2)

O W 21.0 (8.9, 41.8) 12.4 (1.9, 51.4) 0.0 0.0 2.1 (0.3, 13.7)

S/Sa 10.4 (6.2, 17.1) 12.3 (7.6, 19.5) 7.9 (4.7, 12.9) 14.4 (9.5, 21.4) 2.4 (1.0, 5.5)

Fa 5.8 (3.7, 8.9) 8.5 (5.9, 12.1) 12.6 (9.1, 17.4) 4.9 (2.9, 8.0) 10.7 (7.6, 14.8)F/F 0.5 (0.1, 3.3) 11.0 (4.0, 26.7) 12.1 (5.0, 26.6) 8.4 (3.6, 18.6) 0.0

C/M 13.2 (6.9, 23.7) 9.7 (5.1, 17.7) 6.2 (3.4, 11.0) 10.9 (5.9, 19.3) 8.1 (4.3, 14.8)

P/D 16.1 (11.2, 22.7) 7.3 (4.5, 11.6) 5.6 (3.0, 10.2) 12.5 (8.1, 18.8) 2.3 (0.7, 6.6)

O 9.8 (4.0, 22.1) 14.0 (5.2, 32.4) 13.7 (6.4, 26.8) 22.4 (11.2, 39.9) 6.9 (2.0, 21.4)

N: C aa a a a aa( a a) . T a a a a a

aa a a .1 Ea a 25+ a .

8/17/2019 repNTI

65/162

65

7.2 S

T 72 aa a a aa a a aa

a . T a / (61.3%), a a/ (35.7%). V

aa a a a a (0.5%), I (0.0%),

(2.6%).

T a a a a a aa.

8/17/2019 repNTI

66/162

T 72: P ≥15 ,

GATS V N, 2010.

G A ()

S O M F 1524 ≥ 25

(95% )

S/K 61.3 (58.1, 64.4) 61.3 (58.1, 64.3) 62.4 (40.8, 80.1) 58.0 (48.6, 66.8) 61.9 (58.5, 65.2)

Ta Sa/S V 35.7 (32.6, 38.8) 35.6 (32.6, 38.8) 37.6 (19.9, 59.2) 39.6 (30.8, 49.1) 34.9 (31.8, 38.2)

D S 0.5 (0.2, 1.2) 0.5 (0.2, 1.3) 0.0 1.7 (0.4, 7.0) 0.2 (0.1, 0.7)

I 0.0 0.0 0.0 0.0 0.0

O 2.6 (1.7, 3.8) 2.7 (1.8, 3.9) 0.0 0.7 (0.2, 2.9) 3.0 (2.0, 4.4)

T 100 100 100 100 100

8/17/2019 repNTI

67/162

67

7.3 C

Ta 7.3 a aa a a aaa

≥15 a , a aa. O aa, a aaa

VND 135,000 (a US$ 7). T a a a VND 91,000

(a US$ 5). Ma aaa VND 135,900/ a a VND 97,200/.

B a, aa a a 84,000/ a a 65 a a a VND

141,900/ a a 4564. B , a aa aa a (VND 180,200/ . VND 110,800/, ). B a,

aa a a a a a (VND 180,200/) a

a a a a (VND 124,700/). B a, aa

a a VND 103,400 a a VND 193,300 a a .

T 73: A ≥15 ,

GATS V N, 2010.

D

C

C

(VND )

A (95% )

O 134.9 (125.8, 143.9) 91.3

Ma 135.9 (126.7, 145.1) 91.3

Fa 97.2 (52.2, 142.2) 42.6

A ()

1524 119.0 (92.8, 145.2) 85.2

2544 140.5 (128.8, 152.2) 97.3

4564 141.9 (124.7, 159.0) 91.3

65+ 80.4 (64.8, 95.9) 60.8

Ua 180.2 (165.5, 194.9) 143.4

Ra 110.8 (99.6, 122.0) 76.0

1

Pa 124.7 (107.3, 142.2) 82.1

L a 128.0 (117.0, 138.9) 89.0

U a 180.2 (150.7, 209.7) 114.1

C a 168.1 (139.8, 196.5) 114.1

Maa/Pa 184.3 (149.5, 219.2) 125.5

O W 193.3 (73.2, 313.4) 152.1

S/Sa 171.8 (149.8, 193.8) 138.4

Fa 103.4 (90.7, 116.1) 76.0

F/F 152.4 (92.0, 212.9) 76.0

C/M 118.0 (97.6, 138.5) 91.3

P/D 177.4 (150.7, 204.2) 121.7

O 162.5 (130.8, 194.2) 152.11 Ea a 25+ a .

8/17/2019 repNTI

68/162

68

7.4 C A

T a a a 100 a aa a a VND 550,000 (a US$ 29). T aa a

100 a aa a a a a G D P (GDP)4 5 aa a 2.7%.

4 Daa GDP aa a W E O, A 2010 Iaa

Ma F (GDP V Na 2009 a 91,854 )

5 Daa a a V Na a Ga Sa O (Pa V Na 2009

a 85.8 )

8/17/2019 repNTI

69/162

69

8. M

8.1 A

T aa aa a a a a

a. T a aa, , a, a, I, a a a a, ,

a a, a a a a a.

T a a a a a a

a a a a , a, a a aa,

, a, a, ., 30 a.

‐

N a aa a a a a

aa, a aa (42.5% . 26.1%), a (54.4% . 39.2%), I (23.4% . 8.5%),

(41.7% . 22.7%), a a/a (10.6% . 6.9%); a aa

a a a (29.9% . 24.2%) a a a a (41.8% . 34.1%).

8/17/2019 repNTI

70/162

70

Ta 81 a 91.6% a a a 15 a a a a a a aa

a a a a a a. T a a a (85.9%),

a (42.8%) a a a a (38.2%). T a a

a a a a (7.7%).

T a a a a a , a a a I a

a a 1524 a (25.5%) a a 25 a (7.3%).

Ma (>25 a) a a a (30.3% . 21.5%) aa a a (40.3% . 32.1%).

Ca , a aa a a a

a a aa, a a (93.9% . 90.7%), a aa (42.2% . 25.7%), a

(53.8% . 37.9%), I (21.8% . 7.6%), a (41.1% . 21.7%). I a, a aa

a a a a (29.5% . 24.7%) a a a

a (40.3% . 33.5%).

‐

Ca a, a a a a

a a a a. Fa a a a

a a a a a. T a a aa a a a 72.5% a a a a 92.3%.

Ga a, 1524 a a a a a

a a a a 25 a (85.2% . 92.7%). T a a a a ,

I a . A 20.7% 1524 a a a

a I a 6.2% a a 25 a .

B , a a a a aa a a aa

a a a . Sa, a a a aa : 95.1% .

90.1% a , 41.2% . 24.5% a a aa, 51.8% . 34% a, 16.4% . 4.8%

I, 39.2% . 18.7% a 10.1% . 4.8% a/a.

‐ ‐

A , 91.6% a a a a a. T a aa a

a a a a a a a. T

a a a a a a a a

a a a a (42.3% .33.7%), a

a a a aa a a a (34.9% .

29.3%).

I a 25 a a , a 1524 a a

a a I (26.2% . 7.7%) a (26.2% . 7.7%). I,

a a a a (21.8% . 30.7%) a a a

a (33.2% . 42.1%). N a aa a a

a a aa, a aa (42.5% . 26.1%), a (54.4% . 39.2%),

I (23.4% . 8.5%), (41.7% . 22.7%), a a/a (10.6% . 6.9%); a

aa a a a (29.9% . 24.2%) a a a a

(41.8% . 34.1%).

8/17/2019 repNTI

71/162

8/17/2019 repNTI

72/162

G A()

P O M F 1524 ≥ 25

(95% )

O a 43.9 (42.1, 45.6) 46.0 (43.0, 49.0) 42.8 (40.9, 44.8) 46.7 (43.3, 50.1) 42.7 (40.9, 4

I 13.1 (12.1, 14.2) 17.7 (15.7, 20.1) 10.8 (9.8, 12.0) 26.2 (23.5, 29.1) 7.7 (6.9,

La a, a 39.4 (37.5, 41.5) 33.7 (31.0, 36.6) 42.3 (40.1, 44.6) 33.2 (29.8, 36.7) 42.1 (40.0, 4

P 28.5 (27.0, 30.1) 29.8 (27.3, 32.5) 27.9 (26.2, 29.6) 28.4 (25.6, 31.3) 28.6 (26.9, 3

La/Pa 8.0 (7.2, 9.0) 7.7 (6.2, 9.4) 8.2 (7.3, 9.2) 7.9 (6.3, 9.8) 8.1 (7.2,

S 13.1 (12.1, 14.2) 17.7 (15.7, 20.1) 10.8 (9.8, 12.0) 26.2 (23.5, 29.1) 7.7 (6.9,

A La 91.6 (90.5, 92.7) 92.3 (90.3, 93.9) 91.3 (90.1, 92.4) 91.5 (89.1, 93.4) 91.7 (90.6, 91I a a aa( a a) .

2 I a .

8/17/2019 repNTI

73/162

73

8.2 N

T a a a a a aa a 30 a a

a a a a a aa a 30 a

.

T a a a a 30 a a

a a a a a a a a 30 a a a a a a .

8/17/2019 repNTI

74/162

74

T 82 a 92.4% a a a a a a 66.7%

a a a a. M a a a

a a a (93.3% . 64.3%) a a a a a (67.6%

. 38.1%).

Ra a, a 65 a a a a a

a a a a (83.9% . 90.1%94.5%). T 65 a a

a a a a a a a a a (51% . 64.4%69.7%).

C a aa a a a a a a

a aa (96.3% . 90.7%). B a a

a a a a.

B a , a a a a a a a a

a a a a, (81.3% . 94.3%98.2%) a a

(51.7% . 69.9%74.7%).

Ra a, a (100%) a a a a a 91.7% a a

a a a. Fa a a a a a (89.4%), a

a/ a (61.5%).

8/17/2019 repNTI

75/162

75

T 82: P ≥15

30 , GATS V N,

2010.

C 1

D

C

N

2

T

2

(95% )

O 92.4 (90.7, 93.8) 66.7 (63.9, 69.4)

Ma 93.3 (91.7, 94.6) 67.6 (64.9, 70.1)

Fa 64.3 (50.4, 76.1) 38.1 (25.1, 53.0)

A ()

1524 94.5 (89.5, 97.1) 66.9 (58.2, 74.6)

2544 94.0 (91.8, 95.7) 69.7 (66.1, 73.0)

4564 90.1 (86.9, 92.6) 64.4 (60.0, 68.6)

65+ 83.9 (76.4, 89.3) 51.0 (42.5, 59.4)

Ua 96.3 (94.6, 97.4) 64.5 (61.0, 67.9)

Ra 90.7 (88.4, 92.6) 67.6 (63.9, 71.1)

3

Pa 81.3 (76.0, 85.6) 51.7 (45.5, 57.8)

L a 94.3 (92.2, 95.8) 69.9 (66.5, 73.1)

U a 97.7 (94.6, 99.0) 74.7 (68.4, 80.1)

C a 98.2 (95.2, 99.4) 74.1 (67.0, 80.2)

Maa/Pa 97.2 (88.5, 99.3) 74.2 (65.2, 81.6)

O W 100.0 91.7 (74.3, 97.7)S/Sa 94.1 (89.3, 96.8) 61.5 (54.7, 67.9)

Fa 89.4 (86.2, 91.9) 67.9 (63.2, 72.1)

F/F 97.1 (88.9, 99.3) 64.0 (47.8, 77.5)

C/M 97.2 (93.4, 98.9) 70.3 (60.6, 78.6)

P/D 96.8 (94.1, 98.3) 66.9 (59.9, 73.2)

O 87.6 (70.3, 95.5) 67.5 (52.3, 79.7)1 I a a aa( a a) .2 D a 30 a.3 Ea a 25+ a .

8/17/2019 repNTI

76/162

76

8.3 N

T a a a a 15 a a a a a a

a. T a aa a a

a a a a .

Ta 83 a a 15 a a a a a a a

a, a a a , , a, a, , a aa,

I, a, /a/aa , aa a, a a.

T a a a a a, a 16.9%. M (19.9%),

1524 a a (25.3%) a a aa (25.1%) a a

a, , a (14.1%), 25 a (14%), a a

aa (13.3%).

Oa, a a a a a (8.6%), aa/ a

(3.7%) a (2.1%), a a a (0.2%). T a a

a a a, a a a a

aa/ a a a a a (4.7% . 2.7%). I a, a (1524)

a a a. I a a 25 a ,

1524 a a a a (13.5% . 6.8%), I (1.1% .

0.2%) a aa/ a (5.8% . 2.9%). T a aa a

a a a aa, a (12.8% . 6.7%), I

(1.0% . 0.1%), a (1.6% . 0.6%) a aa/ a (7.4% . 2.0%).

T a a a a a 0.9%. M a 1524 a

a (1.2% . 0.6%) a a 25 a (1.6% . 0.7%), .

Ra a , a a a a a

(3.2%) a a a a (0.2%). T a a

a a 0.6%.

8/17/2019 repNTI

77/162

8/17/2019 repNTI

78/162

78

8.4 N

T a a a 15 a a a a a

a a. T a a aa a

15 a a a a a a a

a 15 a a.

T 84 a a a a, , a, a a , a a .

Oa, 19.1% a a a, . C

1524 a a a aa a a a,

a a a 25 (27.9% . 17.6%), a a aa (30.5% . 14.2%),

.

T a a a a a a a a. T

a a a (9.4%) a a ,

a, a I (0.2%). A 1524 a a a

a 25 a a a (16.8% . 8.2%). Ca a aa, a

aa a a (15.3% . 6.9%) a aa/ a (7.9% . 2.5%).

T a a a 0.8%. T a a

a a a , a a aa. T a

a (, a, a/a) a 0.5%. T a

a a aa a a a a aa (1.3% . 0.1%,

).

8.5 N

T a a a 15 a a a a a

a. T a aa a 15 a a a a a a a a 15 a a.

T 85 a a a a, a a

a a a a a a.

8/17/2019 repNTI

79/162

8/17/2019 repNTI

80/162

8/17/2019 repNTI

81/162

81

9. K, A P

9.1 B

T a a a a aa a a a . Ta

91 a a aa a a

a . A a a (95.7%) a a a a .

T a aa a a a (95.6%), (70.3%), a a aa

(62.7%) a a 55.5% a a a a a.

Ra a , a , , a aa

a a a (65 a a). Ua a a a a a

a a a a. K a a a a a a

a a a a .

Ta 92 aa a a ,

, a aa, , a a a .

C aa a a . D

a a, a aa a a a a .

T a a a a a aa a a a

( a 31.5%). T a a aa a aa, a a a a

a ( a 22.4%).

A a , a 65 a a aa a

a a a .

A aa , a a a a a a

aa : (83.6% . 94.4%97.2%); (44.4% . 65.9% 71.9%); a aa

(42.8% . 56.7%71.2%), a (83.7% . 93.2%97.1%), a a a (35.2% . 50.1%62.5%).

A aa , a a a a .

‐

A Ta 93, a aa a a a

a a a a.

A a (96.8%) a a a a . T a

a a a (96.8%), (72.5%), a a aa (64.8%)

57.5% a a a a a.

Ra a , a , , a aa

a a, a (65 a a).

Ua aa a a a . N

a a a a aa a a

aa . A a , a a a /

.

8/17/2019 repNTI

82/162

82

T 91: P ≥15 , , ,

, GATS V N, 2010.

A

D

C S S H L

S A H

A A L

C(95% )

O 95.7 (95.0, 96.3) 70.3

Documents

repNTI